Invitrogen Life Science > Products & Services > Applications > Cell & Tissue Analysis > Antibodies & Secondary Detection > Cell Junction Antibody References

Cell Junction Antibody References

High quality Zymed® cell junction antibodies from Invitrogen produce highly specific identification of target proteins. You'll detect only the junction protein you want, not all of those in the surrounding vicinity. In fact, Zymed® antibodies are widely used and cited in the literature, demonstrating their reliability in a variety of different applications. See below for a select list of publications referencing our cell junction antibodies.

View references for these product types:

Adherens Junction Antibody Products
Gap Junction Antibody Products
Tight Junction Antibody Products

Cat #	Product	Authors	Journal	Volume	Page(s)	Year	Application(s)
Adherens Junction Antibody Product References
13-1700	Ms anti-E-cadherin (HECD-1)	Hoover KB, et al.	Am J Pathol	153(6)	1767-1773	1998	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Auersperg N, et al.	PNAS	96	6249-6254	1999	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Day ML, et al.	J Biol Chem	274(14)	9656-9664	1999	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Corn PG, et al.	Clin Cancer Res	6	4243-4248	2000	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Gottardi CJ, et al.	J Cell Biol	153(5)	1049-1059	2000	WB, IF
13-1700	Ms anti-E-cadherin (HECD-1)	Hazan RB, et al.	J Cell Biol	148(4)	779-790	2000	WB, IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Heimann R, et al.	Cancer Res	60	298-304	2000	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Hsu M, et al.	J Cell Sci	113	1535-1542	2000	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Acs G, et al.	Arch Pathol Lab Med	125	198-201	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Adam L, et al.	J Biol Chem	276(30)	28443-28450	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Gallicano GI, et al.	Development	128	929-941	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Gregoire L, et al.	Clin Cancer Res	7	4280-4287	2001	WB, IHC (paraffin)
13-1700	Ms anti-E-cadherin (HECD-1)	Jacobs TW, et al.	Am J Surg Pathol	25(2)	229-36	2001	IHC(FFPE)1:500
13-1700	Ms anti-E-cadherin (HECD-1)	Kaplan DK, et al.	J Biol Chem	276(47)	44037-44043	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Luo Y, et al.	Development	128	459-469	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Machado JC, et al.	Oncogene	20	1525-1528	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Meigs TE, et al	PNAS	98(2)	519-534	2001	IF, WB
13-1700	Ms anti-E-cadherin (HECD-1)	Naora H, et al.	PNAS	98(26)	15209-15214	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Rashid MG, et al.	Cancer Res	61	489-492	2001	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Vallorosi CJ, et al.	J Biol Chem	275(5)	3328-3334	2001	IP and WB
13-1700	Ms anti-E-cadherin (HECD-1)	Zavadil J, et al.	PNAS	98(12)	6686-6691	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Zhong Y, et al.	Clin Cancer Res	7	1683-1687	2001	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Alpaugh ML, et al.	Oncogene	21	3631-3643	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Edens HA, et al.	J Immunol	169	476-486	2002	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Govindarajan R, et al.	J Biol Chem	277(51)	50087-50097	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Hajra KM, et al.	Cancer Res	62	1613-1618	2002	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Kim J-T, et al.	J Biol Chem	277(35)	31938-31948	2002	IF, adhesion blocking studies
13-1700	Ms anti-E-cadherin (HECD-1)	Laura RP, et al.	J Biol Chem	277(15)	12906-12914	2002	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Li Q, et al.	J Biol Chem	277(48)	46447-46455	2002	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Muller N, et al.	Oncogene	21	6049-6058	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Niessen CM, Gumbiner BM.	J Cell Biol	156(2)	389-399	2002	?
13-1700	Ms anti-E-cadherin (HECD-1)	Sahai E, Marshall CJ.	Nature Cell Biol	4	408-415	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Tran NL, et al.	J Biol Chem	277(36)	32905-32914	2002	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Weaver VM, et al.	Cancer Cell	2	205-216	2002	blocking
13-1700	Ms anti-E-cadherin (HECD-1)	Boussioutas A, et al.	Cancer Res	63	2569-2577	2003	IHC (paraffin)
13-1700	Ms anti-E-cadherin (HECD-1)	Chan AOO, et al.	J Clin Oncol	21(12)	2288-2293	2003	IHC (paraffin, 1:200)
13-1700	Ms anti-E-cadherin (HECD-1)	Kowalski PJ, et al.	Breast Cancer Res	5	R217-R222	2003	IHC (FFPE, Ventana Biotek Techmate 500)
13-1700	Ms anti-E-cadherin (HECD-1)	Kuefer R, et al.	Clin Cancer Res	9(17)	6447-6452	2003	WB (Hu prostate)
13-1700	Ms anti-E-cadherin (HECD-1)	Rios-Doria J, et al.	J Biol Chem	278(2)	1372-1379	2003	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Suriano G, et al.	Hum Mol Genet	12	575-582	2003	IHC (froz)
13-1700	Ms anti-E-cadherin (HECD-1)	Tian F, et al.	Cancer Res	63	8284-8292	2003	IF, WB
13-1700	Ms anti-E-cadherin (HECD-1)	Troyanovsky RB, et al.	Mol Cell Biol	23(22)	7965-7972	2003	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Gottardi CJ, Gumbiner BM.	Am J Physiol Cell Physiol	286	C747-756	2004	WB (1:10,000)
13-1700	Ms anti-E-cadherin (HECD-1)	Haven CJ, et al.	Cancer Res	64(20)	7405-7411	2004	IHC (paraffin, 1:500)
13-1700	Ms anti-E-cadherin (HECD-1)	Ivanov AI, et al.	Mol Cell Biol	15(6)	2639-2651	2004	IF (Hu)
13-1700	Ms anti-E-cadherin (HECD-1)	Lecuit M, et al.	PNAS	101(16)	6152-6157	2004	IHC (FFPE and froz, 1:500)
13-1700	Ms anti-E-cadherin (HECD-1)	Tobey NA, et al.	Am J Physiol Gastrointest Li ver Physiol	286	G1042-1049	2004	IHC (Rb, PFA-fixed, paraffin)
13-1700	Ms anti-E-cadherin (HECD-1)	Peignon G, et al.	J Biol Chem	281(6)	3560-3568	2006	IF (1:200)
13-1700	Ms anti-E-cadherin (HECD-1)	Horiguchi Y, et al.	J Histochem Cytochem	42(10)	1333-1340	1994	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Watabe M, et al.	J Cell Biol	127(1)	247-256	1994	IP
13-1700	Ms anti-E-cadherin (HECD-1)	Blauvelt A, et al.	J Invest Dermatology	104	193-6	1995	Flow Cytometry
13-1700	Ms anti-E-cadherin (HECD-1)	Glukhova M, et al.	Am J Pathol	146	706-716	1995	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Sanna M, et al.	Anat Pathol	105(4)	394-402	1995	IHC (frozen)
13-1700	Ms anti-E-cadherin (HECD-1)	Siitonen SM, et al.	Anatomic Pathology	105(4)	394-402	1996	IHC (1:800)
13-1700	Ms anti-E-cadherin (HECD-1)	Braga VMM, et al.	J Cell Biol	137(6)	1421-1431	1997	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Hoover KB, et al.	Am J Pathol	153(6)	1767-1773	1998	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Kondo K, et al.	Cancer Res	58	2014-2019	1998
13-1700	Ms anti-E-cadherin (HECD-1)	Soto H, et al.	Human Pathology	30(11)	1344-1349	1999
13-1700	Ms anti-E-cadherin (HECD-1)	Acs G, et al.	Arch Pathol Lab Med	125	198-201	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Vallorosi CJ, et al.	J Biol Chem	275(5)	3328-3334	2001	IP and WB
13-1700	Ms anti-E-cadherin (HECD-1)	Zavadil, et al.	PNAS	98(12)	7573-7578	2001	IF and WB
13-1800	Rt anti-E-cadherin (ECCD-1)	Tinkle CL, et al.	PNAS	101(2)	552-557	2004	WB, IF
13-1800	Rt anti-E-cadherin (ECCD-1)	Takeichi M.	Development	102	639-655	1988	WB
13-1800	Rt anti-E-cadherin (ECCD-1)	Hirai Y, et al.	Development	105	271-277	1989	Cell-cell adhesion blocking (pos), IHC
13-1800	Rt anti-E-cadherin (ECCD-1)	Nose A, et al.	Cell	61	147-155	1990	Epitope Mapping
13-1800	Rt anti-E-cadherin (ECCD-1)	Tang A, et al.	Nature	361	82-85	1993	Binding comp,
13-1800	Rt anti-E-cadherin (ECCD-1)	Babich M, et al.	Life Sciences	54(11)	PL-201-PL20 8	1994	Immunostain
13-1800	Rt anti-E-cadherin (ECCD-1)	Fannon A, et al.	J Cell Biol	129 (1)	189-202	1995
13-1800	Rt anti-E-cadherin (ECCD-1)	Roh J-Y, et al.	J Cell Biol	128(5)	939-947	1995	Cell-cell adhesion blocking (pos)
13-1900	Rt anti-E-cadherin (ECCD-2)	Hosono S, et al.	J Biol Chem	275(15)	10943-10953	2000	WB
13-1900	Rt anti-E-cadherin (ECCD-2)	Mulac-Jericevic B, et al.	Science	289	1751-1754	2000	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Carothers AM, et al.	J Biol Chem	276(42)	39094-39102	2001	WB, IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Bouchard M, et al.	Genes Dev	16(22)	2958-2970	2002	IHC (Ms)
13-1900	Rt anti-E-cadherin (ECCD-2)	DasGupta R, et al.	J Cell Biol	158(2)	331-344	2002	IF (Ms), WB
13-1900	Rt anti-E-cadherin (ECCD-2)	Gritli-Linde A, et al.	Development	129	5323-5337	2002	IHC (Ms, PFA, paraffin)
13-1900	Rt anti-E-cadherin (ECCD-2)	Lopez T, Hanahan D.	Cancer Cell	1	339-353	2002	IHC - frozen, Ms
13-1900	Rt anti-E-cadherin (ECCD-2)	Ngan ESW, et al.	PNAS	99(17)	11187-11192	2002	IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Pelengaris S, et al.	Cell	109	321-334	2002	IHC - paraffin, Ms
13-1900	Rt anti-E-cadherin (ECCD-2)	Wali RK, et al.	Cancer Epidemiol Biomarker s Prev	11	1653-1662	2002	WB, IHC (rat)
13-1900	Rt anti-E-cadherin (ECCD-2)	Welm BE, et al.	J Cell Biol	157(4)	703-714	2002	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Yoon M, Spear PG.	J Virol	76(14)	7203-7208	2002	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Davis J, et al.	J Cell Sci	116	2157-2167	2003	WB, IHC (Ms eye, froz, 0.1ug/mL)
13-1900	Rt anti-E-cadherin (ECCD-2)	Gouyon F, et al.	J Physiol	552	823-832	2003
13-1900	Rt anti-E-cadherin (ECCD-2)	Kopp T, et al.	J Immunol	171	5438-5444	2003	FC
13-1900	Rt anti-E-cadherin (ECCD-2)	Lallemand D, et al.	Genes Dev	17(9)	1090-1100	2003	IF (Ms, 1:250)
13-1900	Rt anti-E-cadherin (ECCD-2)	Sakai T, et al.	Genes Dev	17(7)	926-940	2003	ICC (Ms)
13-1900	Rt anti-E-cadherin (ECCD-2)	Devaux JJ, et al.	J Neurosci	24(5)	1236-1244	2004	IHC (Ms, Rt, froz, 1:50)
13-1900	Rt anti-E-cadherin (ECCD-2)	Fouquet S, et al.	J Biol Chem	279(41)	43061-43069	2004	IF (Ms intestine, 1:250), WB (1:2,500)
13-1900	Rt anti-E-cadherin (ECCD-2)	Hogan C, et al.	Mol Cell Biol	24(15)	6690-6700	2004	IF (Hu)
13-1900	Rt anti-E-cadherin (ECCD-2)	Linehan MM, et al.	J Virol	78	2530-2536	2004	IF (Ms, froz)
13-1900	Rt anti-E-cadherin (ECCD-2)	Oshima RG, et al.	Cancer Res	64	169-179	2004	IF (Ms tissue, froz)
13-1900	Rt anti-E-cadherin (ECCD-2)	Wandzioch E, et al.	PNAS	101(47)	16549-16554	2004	IHC (Ms embryo, paraffin)
13-1900	Rt anti-E-cadherin (ECCD-2)	Tricaud N, et al.	J Neurosci	25(13)	3259-3269	2005	IHC (Ms sciatic nerve, froz)
13-1900	Rt anti-E-cadherin (ECCD-2)	Peignon G, et al.	J Biol Chem	281(6)	3560-3568	2006	IF (1:250)
13-1900	Rt anti-E-cadherin (ECCD-2)	Takeichi M.	Development	102	639-655	1988	IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Hirai Y, et al.	Development	105	271-277	1989	Cell-cell adhesion blocking (neg ctrl)
13-1900	Rt anti-E-cadherin (ECCD-2)	Hirano S, et al.	Cell	70	293-301	1992	WB, IP
13-1900	Rt anti-E-cadherin (ECCD-2)	Tang A, et al.	Nature	361	82-85	1993	Flow
13-1900	Rt anti-E-cadherin (ECCD-2)	Babich M and Foti RP.	Life Sciences	54(11)	PL-201-PL20 8	1994	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Horiguchi Y, et al.	J Histochem Cytochem	42(10)	1333-1340	1994	IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Nagafuchi A, et al.	J Cell Biol	127(1)	235-245	1994	IB,IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Tsarfaty I, et al.	Science	263	98-101	1994	IHC (paraffin)
13-1900	Rt anti-E-cadherin (ECCD-2)	Watabe M, et al.	J Cell Biol	127(1)	247-251	1994
13-1900	Rt anti-E-cadherin (ECCD-2)	Fannon AM, et al.	J Cell Biol	129(1)	189-202	1995	IP, WB, IHC (frozen)
13-1900	Rt anti-E-cadherin (ECCD-2)	Palacios J, et al.	Am J Pathol	146	605-612	1995	IHC(oct)
13-1900	Rt anti-E-cadherin (ECCD-2)	Roh J-Y, et al.	J Cell Biol	128(5)	939-947	1995	IP, IF, WB, Flow
13-1900	Rt anti-E-cadherin (ECCD-2)	Shibamoto S, et al.	J Cell Biol	128(5)	949-957	1995	HECD-2-IP, WB
13-1900	Rt anti-E-cadherin (ECCD-2)	Mbalaviele G, et al.	Cancer Res	56	4063-4070	1996	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Braga VMM, et al.	J Cell Biol	137(6)	1421-1431	1997
13-1900	Rt anti-E-cadherin (ECCD-2)	Dunn RJ, et al.	J Histochem Cytochem	45(1)	129-141	1997	IHC (frozen/OCT)
13-1900	Rt anti-E-cadherin (ECCD-2)	Gallicano GI, et al.	J Cell Biol	143(7)	2009-2022	1998	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Perl AK, et al.	Nature Med	5(3)	286-291	1999	F
13-2000	Rt anti-P-cadherin	Liu G, et al.	J Clin Invest	112(2)	209-221	2003	Injected into rats
13-2000	Rt anti-P-cadherin	Tinkle CL, et al.	PNAS	101(2)	552-557	2004	WB, IF
13-2000	Rt anti-P-cadherin	Rico M, et al.	Am J Physiol Renal Physiol	289	F431-441	2005	IF (1:50)
13-2000	Rt anti-P-cadherin	Takeichi, M.	Development	102	639-655	1988	Adhesion Inhibition
13-2000	Rt anti-P-cadherin	Hirai Y, et al.	Development	105	271-277	1989	Cell-cell adhesion blocking (pos), IHC
13-2000	Rt anti-P-cadherin	Nose A, et al.	Cell	61	147-155	1990	Epitope Mapping
13-2000	Rt anti-P-cadherin	Tang A, et al.	Nature	361	82-85	1993	Inhibition studies,
13-2000	Rt anti-P-cadherin	Roh J-Y, et al.	J Cell Biol	128(5)	939-947	1995	Cell-cell adhesion blocking (neg. cntl.)
13-2000	Rt anti-P-cadherin	Jamora C, et al.	Nature	422	317-322	2003	IHC
13-2100	Rt anti-N-cadherin (NCD-2)	Mahlapuu M, et al.	Development	128	155-166	2001	IHC
13-2100	Rt anti-N-cadherin (NCD-2)	Ryan PL, et al	PNAS	98(8)	4323-4327	2001	ICC
13-2100	Rt anti-N-cadherin (NCD-2)	Robinson EE, et al.	J Cell Sci	116	377-386	2003	FC
13-2100	Rt anti-N-cadherin (NCD-2)	Ciesiolka M, et al.	J Cell Sci	117	4325-4339	2004	WB (Xen)
13-2100	Rt anti-N-cadherin (NCD-2)	Hatta K, et al.	Nature	320(6061)	447-449	1986	WB, IHC (frozen)
13-2100	Rt anti-N-cadherin (NCD-2)	Takeichi M.	Development	102	639-655	1988	Adhesion Inhibition
13-2100	Rt anti-N-cadherin (NCD-2)	Nose A, et al.	Cell	61	147-155	1990	Epitope Mapping
13-2100	Rt anti-N-cadherin (NCD-2)	Hirano S, et al.	Cell	70	293-301	1992	WB, IP, IF
13-2100	Rt anti-N-cadherin (NCD-2)	Bixby JL, et al.	J Neurosci	13(8)	3421-3432	1993	WB
13-2100	Rt anti-N-cadherin (NCD-2)	Balsamo J, et al.	J Cell Biol	129(5)	1391-1401	1995	Affinity Chromatography, WB
13-2100	Rt anti-N-cadherin (NCD-2)	Zong CS, et al.	J Biol Chem	272(3)	1500-1506	1997	WB ( no data shown )
13-2100	Rt anti-N-cadherin (NCD-2)	Huttenlocher A, et al.	J Cell Biol	141(2)	515-526	1998	cell inhibition
13-5700	Ms anti-E-cadherin (SHE78-7)	Day ML, et al.	J Biol Chem	274(14)	9656-9664	1999	blocking studies
13-5700	Ms anti-E-cadherin (SHE78-7)	Mueller S, et al.	Cancer Res	60	156-163	2000	blocking studies
13-5700	Ms anti-E-cadherin (SHE78-7)	Reinacher-Schick A, Gumbiner BM.	J Cell Biol	152(3)	491-502	2001	WB
13-5700	Ms anti-E-cadherin (SHE78-7)	Klingelhofer J, et al.	Oncogene	22	1181-1188	2003
13-5700	Ms anti-E-cadherin (SHE78-7)	Mariner DJ, et al.	J Cell Sci	117	1339-1350	2004	Blocking (1ug/mL)
13-5700	Ms anti-E-cadherin (SHE78-7)	Merot Y, et al.	J Biol Chem	279(25)	26184-26191	2004	WB (1:1000)
13-5700	Ms anti-E-cadherin (SHE78-7)	Dalrymple S, et al.	Cancer Res	65	9269-9279	2005	Blocking (2ug/mL)
13-5700	Ms anti-E-cadherin (SHE78-7)	Pang J-H, et al.	J Biol Chem	280(4)	3043-3050	2005	IP
13-5700	Ms anti-E-cadherin (SHE78-7)	Katayama M, et al.	J Oncol Int	5	1049-1057	1994	ELISA, WB, Adhesion Inhibition
13-5700	Ms anti-E-cadherin (SHE78-7)	Watabe M, et al.	J Cell Biol	127(1)	247-256	1994	IP
13-5700	Ms anti-E-cadherin (SHE78-7)	Mitra, et al.	Lab Invest	76	99-107	1997	Blocking
13-5700	Ms anti-E-cadherin (SHE78-7)	St. Croix B, et al.	J Cell Biol	142(2)	557-571	1998	Inhibition
13-5700	Ms anti-E-cadherin (SHE78-7)	Orford K, et al.	J Cell Biol	146(4)	855-867	1999
13-5800	Ms anti-P-cadherin	Muller N, et al.	Oncogene	21	6049-6058	2002
13-5800	Ms anti-P-cadherin	Shimoyama Y, et al.	J Cell Biol	109	1787-1794	1989	ICC, WB, cell-cell adhesion blocking (pos)
13-5800	Ms anti-P-cadherin	Shimoyama Y, et al.	Cancer Res	49	2128-2133	1989	WB, IHC (frozen)
13-5800	Ms anti-P-cadherin	Shimoyama Y, et al.	Cancer Res	51	2185-2192	1991	WB, IHC
13-5800	Ms anti-P-cadherin	Doki Y, et al.	Cancer Res	53	3421-3426	1993	WB
13-5800	Ms anti-P-cadherin	Morton RA, et al.	Cancer Res	53	3585-3590	1993	IF, WB, IP
13-5800	Ms anti-P-cadherin	Rasbridge SA.	J Pathol	169	245-250	1993	IHC (frozen)
13-5800	Ms anti-P-cadherin	Yasui W, et al.	Internation J of Cancer	54	49-52	1993	WB, IHC (frozen)
13-5800	Ms anti-P-cadherin	Hodivala KJ.	J Cell Biol	124(4)	589-600	1994	IF, Stratification Inhibition
13-5800	Ms anti-P-cadherin	Glukhova M, et al.	Am J Pathol	146	706-716	1995	IF
13-5800	Ms anti-P-cadherin	Palacios J, et al.	Am J Pathol	146	605-612	1995	IHC(oct)
13-5800	Ms anti-P-cadherin	Braga VMM, et al.	J Cell Biol	137 (6)	1421-1431	1997
13-8400	Ms anti-beta-Catenin	Sakanaka C, Williams LT.	J Biol Chem	274(20)	14090-14093	1999	IP
13-8400	Ms anti-beta-Catenin	Woo PL, et al.	J Biol Chem	274(46)	32818-32828	1999	ICC
13-8400	Ms anti-beta-Catenin	Tachibana K, et al.	J Cell Biol	150(5)	1161-1175	2000	IF
13-8400	Ms anti-beta-Catenin	Adam L, et al.	J Biol Chem	276(30)	28443-28450	2001	IP, IF
13-8400	Ms anti-beta-Catenin	Dottori M, et al	Development	128	4127-4138	2001	IHC
13-8400	Ms anti-beta-Catenin	Kaplan DK, et al.	J Biol Chem	276(47)	44037-44043	2001	WB, IF
13-8400	Ms anti-beta-Catenin	Meigs TE, et al.	PNAS	98(2)	519-534	2001	WB, IF
13-8400	Ms anti-beta-Catenin	Rashid MG, et al.	Cancer Res	61	489-492	2001	IP, WB
13-8400	Ms anti-beta-Catenin	Vallorosi CJ, et al.	J Biol Chem	275(2)	3328-3334	2001	IP and WB
13-8400	Ms anti-beta-Catenin	Carmichael J, et al.	J Biol Chem	277(37)	33791-33798	2002	WB, ICC
13-8400	Ms anti-beta-Catenin	Kramer KL, et al.	Cell	111	981-990	2002	WB
13-8400	Ms anti-beta-Catenin	Ren J, et al.	J Biol Chem	277(20)	17616-17622	2002	WB
13-8400	Ms anti-beta-Catenin	Swinney DC, et al.	J Biol Chem	277(26)	23573-23581	2002	ELISA
13-8400	Ms anti-beta-Catenin	Warchol ME.	J Neurosci	22(7)	2607-2616	2002	ICC (Ck)
13-8400	Ms anti-beta-Catenin	Bamji SX, et al.	Neuron	40	719-731	2003	IF (rats)
13-8400	Ms anti-beta-Catenin	Luo Y, Radice GL.	J Cell Sci	116	1471-1479	2003	ICC (Ms, PFA-fixed, 1:100)
13-8400	Ms anti-beta-Catenin	Matsumura K, et al.	Blood	101	1367-1374	2003
13-8400	Ms anti-beta-Catenin	Rios-Doria J, et al.	J Biol Chem	278(2)	1372-1379	2003	IP
13-8400	Ms anti-beta-Catenin	Hill DA, et al.	J Cell Sci	117	5847-5854	2004	WB
13-8400	Ms anti-beta-Catenin	Kaplan DD, et al.	J Biol Chem	279(12)	10829-10832	2004	IF
13-8400	Ms anti-beta-Catenin	Li WY, et al.	Am J Physiol Renal Physiol	286	F1063-1071	2004	IF (Ms kidney, froz, 1:100)
13-8400	Ms anti-beta-Catenin	Ogawa T, et al.	J Cell Sci	117	2087-2096	2004	WB (Rt, 1:2,000)
13-8400	Ms anti-beta-Catenin	Yamamoto M.	J Biol Chem	272(19)	12492-12494	1997	IP, WB
13-8400	Ms anti-beta-Catenin	Sakanaka C, et al.	PNAS	95	3020-3023	1998	IP
13-8400	Ms anti-beta-Catenin	Wu S, et al.	PNAS	95	14979-14984	1998	WB
13-8400	Ms anti-beta-Catenin	Meigs TE, et al.	PNAS	98(2)	519-534	2001	WB, IF
13-8400	Ms anti-beta-Catenin	Vallorosi CJ, et al.	J Biol Chem	275(5)	3328-3334	2001	IP and WB
13-8500	Ms anti-gamma-Catenin	Ilan N, et al.	J Biol Chem	275(28)	21435-21443	2000	IHC
13-8500	Ms anti-gamma-Catenin	Grooteclaes M, et al.	PNAS	100(8)	4568-4573	2003	WB
13-8500	Ms anti-gamma-Catenin	Klingelhofer J, et al.	Oncogene	22	1181-1188	2003
13-8500	Ms anti-gamma-Catenin	Li Y, et al.	Molec Cancer Res	1	765-775	2003	WB, IF
13-8500	Ms anti-gamma-Catenin	Kaplan DD, et al.	J Biol Chem	279(12)	10829-10832	2004	WB
13-8500	Ms anti-gamma-Catenin	Descargues P, et al.	Nature Genetics	37	56-65	2005	WB, IHC (ms)
13-8500	Ms anti-gamma-Catenin	Silberberg M, et al.	Am J Physiol Renal Physiol	288	F1153-1163	2005	Confocal IF (Hu kidney, 1:100)
13-9700	Ms anti-alpha-Catenin	Allport JR, et al.	J Cell Biol	148(1)	203-216	1999	IF
13-9700	Ms anti-alpha-Catenin	Giannini AL, et al.	J Biol Chem	275(29)	21883-21888	2000	WB
13-9700	Ms anti-alpha-Catenin	Carothers AM, et al.	J Biol Chem	276(42)	39094-39102	2001	WB
13-9700	Ms anti-alpha-Catenin	Scheffers MS, et al.	Hum Mol Genet	11	59-67	2002
13-9700	Ms anti-alpha-Catenin	Jacquemier J, et al.	Cancer Res	65(3)	767-779	2005	IHC (FFPE)
13-9700	Ms anti-alpha-Catenin	Allport JR, et al.	J Exp Med	186	517-527	1997	IF
13-9700	Ms anti-alpha-Catenin	Yamamoto M.	J Biol Chem	272(19)	12492-12494	1997	IP, WB
32-6100	Ms anti-Desmoglein-2	Silberberg M, et al.	Am J Physiol Renal Physiol	288	F1153-1163	2005	IF (Hu kidney cells, 1:25)
33-3900	Ms anti-N-cadherin	Hazan RB, et al.	J Cell Biol	148(4)	779-790	2000	WB, IHC, migration inhibition
33-3900	Ms anti-N-cadherin	van Raamsdock CD, et al.	Development	127	5439-5448	2000	IHC
33-3900	Ms anti-N-cadherin	Gottardi CJ, et al.	J Cell Biol	153(5)	1049-1059	2001	WB
33-3900	Ms anti-N-cadherin	Janssens B, et al.	J Cell Sci	114	3177-3188	2001	IF
33-3900	Ms anti-N-cadherin	Kotelevets L, et al.	J Cell Biol	155(7)	1129-1135	2001	WB
33-3900	Ms anti-N-cadherin	Luo Y, et al.	Development	128	459-469	2001	IHC
33-3900	Ms anti-N-cadherin	Xu X, et al.	J Cell Biol	154(1)	217-229	2001	IHC
33-3900	Ms anti-N-cadherin (3B9)	Andrieux A, et al.	Genes Dev	16(18)	2350-2364	2002	WB (Ms)
33-3900	Ms anti-N-cadherin	Laura RP, et al.	J Biol Chem	277(15)	12906-12914	2002	WB
33-3900	Ms anti-N-cadherin	Niessen CM, Gumbiner BM.	J Cell Biol	156(2)	389-399	2002	IF
33-3900	Ms anti-N-cadherin	Suyama K, et al.	Cancer Cell	2	301-314	2002	WB, IP
33-3900	Ms anti-N-cadherin (3B9)	Davani S, et al.	Circulation	108	253-258	2003	IHC (Rt heart, paraffin,
33-3900	Ms anti-N-cadherin	Kang J-S, et al.	PNAS	100(7)	3989-3994	2003	WB
33-3900	Ms anti-N-cadherin	Krueger SR, et al.	Neuron	40	945-957	2003	IF (rats)
33-3900	Ms anti-N-cadherin (3B9)	Luo Y, Radice GL.	J Cell Sci	116	1471-1479	2003	ICC (Ms, PFA-fixed, 1:100)
33-3900	Ms anti-N-cadherin (3B9)	Robinson EE, et al.	J Cell Sci	116	377-386	2003	WB
33-3900	Ms anti-N-cadherin (3B9)	Rubinek T, et al.	J Clin Endocrinol Metab	88(8)	3724-3730	2003	IF (paraffin, 1:100)
33-3900	Ms anti-N-cadherin (3B9)	Bharti S, et al.	Mol Cell Biol	15(1)	397-406	2004	WB
33-3900	Ms anti-N-cadherin (3B9)	Hill DA, et al.	J Cell Sci	117	5847-5854	2004	WB
33-3900	Ms anti-N-cadherin (3B9)	Luo Y, Radice GL.	J Cell Biol	169(1)	29-34	2005	IF (HUVEC, HVMEC), Confirmation of siRNA knockdown (IF)
33-3900	Ms anti-N-cadherin (3B9)	Pon YL, et al.	J Biol Chem	280(15)	15438-15448	2005	IP, WB (1:1,000)
33-3900	Ms anti-N-cadherin (3B9)	Siu MKY, et al.	J Biol Chem	280(26)	25029-25047	2005	IP
33-3900	Ms anti-N-cadherin (3B9)	Wattel S, et al.	Oncogene	24	6902-6916	2005	WB, IHC (Hu thyroid adenoma, froz)
33-3900	Ms anti-N-cadherin (3B9)	Wei C-J, et al.	J Biol Chem	280(20)	19925-19936	2005	WB, ICC
33-4000	Ms anti-E-cadherin (4A2C7)	Kim M-K, et al.	App Immunohistochem Mole c Morphol	10(4)	332-338	2002	IHC (paraffin)
33-4000	Ms anti-E-cadherin (4A2C7)	Luo Y, Radice GL.	J Cell Sci	116	1471-1479	2003	ICC (Ms, PFA-fixed, 1:100)
33-4000	Ms anti-E-cadherin (4A2C7)	Palacios J, et al.	Clin Cancer Res	9(10)	3606-3614	2003	IHC (Hu breast cancer, paraffin, 1:200)
33-4000	Ms anti-E-cadherin (4A2C7)	Guerini V, et al.	Cancer Res	65(12)	5445-5453	2005	WB (1:200)
33-9600	Ms anti-p120 Catenin (C-term)	Wu J, et al.	Hybridoma	17(2)	175-183	1999	WB, IP, IF
33-9600	Ms anti-p120 Catenin (C-term)	Humtsoe JO, et al.	EMBO J	22	1539-1554	2003	WB
33-9600	Ms anti-p120 Catenin	Tinkle CL, et al.	PNAS	101(2)	552-557	2004	WB, IF
33-9700	Ms anti-p120 Catenin (N-term)	Wu J, et al.	Hybridoma	17(2)	175-183	1999	WB, IP, IF
33-9700	Ms anti-p120 Catenin (N-term)	Wadham C, et al.	Mol Biol Cell	14(6)	2520-2529	2003	WB
35-4700	Ms anti-Ksp-cadherin	Thedieck C, et al.	Br J Cancer	92	2010-2017	2005	ICC (Hu RCC cells, 1:50), IHC (Hu kidney, froz, 1:50)
35-4700	Ms anti-Ksp-cadherin	Yamamoto M, et al.	Am J Physiol Renal Physiol	290	F52-60	2006	IHC (Ms froz, 1:100), confocal IF
71-1200	Rb anti-alpha-Catenin	Quinlan MP, Hyatt JL.	Cell Growth Differ	10	839-854	1999	IP, IF
71-1200	Rb anti-alpha-Catenin	Mauro L, et al.	J Biol Chem	276(43)	39892-39897	2001	WB, IP
71-1200	Rb anti-alpha-Catenin	Meyer TN, et al.	Am J Physiol Cell Physiol	285	C1281-1293	2003	IP, WB
71-1200	Rb anti-alpha-Catenin	Mucha DR, et al.	Am J Physiol Heart Circ Phy siol	284	H994-1002	2003	ICC (Bv, 1:100)
71-1200	Rb anti-alpha-Catenin	Hinz B, et al.	Mol Cell Biol	15(9)	4310-4320	2004	WB (Rt)
71-1200	Rb anti-alpha-Catenin	Osta WA, et al.	Cancer Res	64(16)	5818-5824	2004	WB
71-1200	Rb anti-alpha-Catenin	Kolly C, et al.	J Invest Dermatol	124	1014-1025	2005	WB (Dog)
71-1200	Rb anti-alpha-Catenin	Margulis A, et al.	Cancer Res	65(5)	1783-1791	2005	WB
71-1200	Rb anti-alpha-Catenin	St Croix B, et al.	J Cell Biology	142(2)	557-571	1998	WB
71-2700	Rb anti-beta-Catenin	Coyne CB, et al.	J Pharmacol Exp Ther	305(2)	440-450	2003	IF (1:1000)
71-2700	Rb anti-beta-Catenin	Meyer TN, et al.	Am J Physiol Cell Physiol	285	C1281-1293	2003	IP, WB
71-2700	Rb anti-beta-Catenin	Walters RW, et al.	Cell	110	789-799	2003	WB, IP, ICC
71-2700	Rb anti-beta-Catenin	Hinz B, et al.	Mol Cell Biol	15(9)	4310-4320	2004	IF (Rt, froz), WB (Rt)
71-2700	Rb anti-beta-Catenin	Osta WA, et al.	Cancer Res	64(16)	5818-5824	2004	WB
71-2700	Rb anti-beta-Catenin	Reymond N, et al.	J Exp Med	199	1331-1341	2004	IF (Hu)
71-2700	Rb anti-beta-Catenin	Margulis A, et al.	Cancer Res	65(5)	1783-1791	2005	IF
71-2700	Rb anti-beta-Catenin	Yongqing L, et al.	J Biol Chem	276(38)	35239-35242	2001	WB
71-7100	Rb anti-pan-cadherin	Colonnese MT, et al.	J Neurophysiol	89	57-68	2003	WB (Rt)
71-7100	Rb anti-pan-cadherin	Croft DR, et al.	Cancer Res	64(24)	8994-9001	2004	IF
71-7100	Rb anti-pan-cadherin	Hinz B, et al.	Mol Cell Biol	15(9)	4310-4320	2004	WB (Rt)
71-7100	Rb anti-pan-cadherin	Ren Y-G, et al.	Mol Cell Biol	15(11)	5064-5074	2004	WB (Hu)
71-7100	Rb anti-pan-cadherin	Schedin PJ, et al.	Oncogene	23	1766-1779	2004	IHC (1:400)
71-7600	Rb anti-cadherin-11	Straub BK, et al.	J Cell Sci	116	4985-4995	2003
71-7600	Rb anti-cadherin-11	Morimoto AM, et al.	Oncogene	23	1618-1626	2004
Gap Junction Antibody Product References
13-8100	Ms anti-CX26 (12H10)	Ito A, et al.	J Clin Invest	105(9)	1189-97	2000	WB 1:300, IHC (PFA-fixed, Hu)
13-8100	Ms anti-CX26 (12H10)	Rash JE, et al.	J Neurosci	21	1983-2000	2001
13-8100	Ms anti-CX26 (12H10)	Rouan F, et al.	J Cell Sci	114	2105-2113	2001	IHC (frozen), WB
13-8100	Ms anti-CX26 (12H10)	Solomon IC, et al.	Resp Pathol	129	101-121	2001	IHC
13-8100	Ms anti-CX26 (12H10)	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF WB
13-8100	Ms anti-CX26 (12H10)	Walcott B, et al.	Am J Physiol Cell Physiol	282	C501-507	2002	WB (1:1000)
13-8100	Ms anti-CX26 (12H10)	Aasen T, et al.	Oncogene	22	7969-7980	2003
13-8100	Ms anti-CX26 (12H10)	Gemel J, et al.	J Cell Sci	117	2469-2480	2004	IF (1:500)
13-8100	Ms anti-CX26 (12H10)	Saito T, et al.	Oncogene	23	1109-1116	2004	IF (1:500)
13-8100	Ms anti-CX26 (12H10)	Thomas T, et al.	J Biol Chem	279(18)	19157-19168	2004	ICC (1:200)
13-8100	Ms anti-Cx26 (CX-12H10)	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005	IF
13-8100	Ms anti-CX26 (12H10)	You S, et al.	Cancer Res	58	1498-1502	1998	IHC (Frozen)
13-8200	Ms anti-CX32 (CX-2C2)	Alvarez-Maubecin V, et al.	J Neurosci	20(11)	4091-4098	2000	ICC (rat)
13-8200	Ms anti-CX32 (CX-2C2)	Peracchia C, et al.	J Biol Chem	275(34)	26220-26224	2000	IF
13-8200	Ms anti-CX32 (CX-2C2)	Rash JE, et al.	PNAS	97(13)	7573-7578	2000	WB
13-8200	Ms anti-CX32 (CX-2C2)	Klepeis VE, et al.	J Cell Sci	114	4185-4195	2001	WB
13-8200	Ms anti-CX32 (CX-2C2)	Rash JE, et al.	J Neurosci	21	1983-2000	2001	WB, Immunogold labeling
13-8200	Ms anti-CX32 (CX-2C2)	Solomon IC, et al.	Resp Pathol	129	101-121	2001	IHC
13-8200	Ms anti-CX32 (CX-2C2)	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF WB
13-8200	Ms anti-CX32 (CX-2C2)	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:500), WB
13-8200	Ms anti-CX32 (CX-2C2)	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
13-8200	Ms anti-CX32 (CX-2C2)	Saito T, et al.	Oncogene	23	1109-1116	2004	IF (1:500)
13-8200	Ms anti-Cx32 (CX-2C2)	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005
13-8200	Ms anti-CX32 (CX-2C2)	Li J, et al.	J Comp Neurol	379(4)	571-591	1997	WB (1:200), IHC (froz), EM
13-8300	Ms anti-CX43	Beardslee MA, et al.	Circ Res	87	656-662	2000	WB IF
13-8300	Ms anti-CX43	Ciray HN, et al.	Am J Obstet Gynecol	182	926-930	2000	IF
13-8300	Ms anti-Cx43	Quist AP, et al.	J Cell Biol	148(5)	1063-1074	2000	IF
13-8300	Ms anti-CX43	Bruzzone S, et al.	J Biol Chem	276(51)	48300-48308	2001	WB
13-8300	Ms anti-CX43	Klepeis VE, et al.	J Cell Sci	114	4185-4195	2001	WB
13-8300	Ms anti-Cx43	Di W-L, et al.	Hum Mol Genet	11	2005-2014	2002	IF (froz, 1:100)
13-8300	Ms anti-CX43	Dubina MV, et al.	Oncogene	21	4992-4996	2002
13-8300	Ms anti-CX43	Piechocki MP, et al.	Clin Cancer Res	8	870-877	2002	IP, WB
13-8300	Ms anti-CX43	Caton D, et al.	J Cell Sci	116	2285-2294	2003	WB (Rt)
13-8300	Ms anti-CX43	Chen J-T, et al.	Clin Cancer Res	9(11)	4200-4204	2003	WB (Hu, 1:1000)
13-8300	Ms anti-CX43	Christ GJ, et al.	Am J Physiol Regulatory Int egrative Comp Physiol	284	R1241-1248	2003	WB (1:500)
13-8300	Ms anti-Cx43	Eugenin EA, et al.	J Immunol	170	1320-1328	2003	WB, IF
13-8300	Ms anti-CX43	Gutstein DE, et al.	J Cell Sci	116	875-885	2003	WB, IF (Ms heart, froz)
13-8300	Ms anti-CX43	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	WB
13-8300	Ms anti-Cx43 (CX-1B1)	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005	IF, WB
13-8300	Ms anti-CX43	Li W, et al.	J Biol Chem	280(9)	7941-7948	2005	WB, IF
13-8300	Ms anti-CX43	Muramatsu T.	J Histochem Cytochem	44(1)	49-56	1996
13-8300	Ms anti-CX43	Hayashi T, et al.	Cancer Letters	112	103-111	1997	WB
13-8300	Ms anti-CX43	Koval M, et al.	J Cell Biol	137(4)	847-857	1997	IF
13-8300	Ms anti-CX43	Masgrau-Peya E, et al.	J Histochem Cytochem	45(9)	1207-1215	1997	IF 1:500dilution
13-8300	Ms anti-CX43	Nagy JI, et al.	Exp Cell Res	236	127-136	1997	WB, IHC, EM
13-8300	Ms anti-CX43	Xie H, et al.	J Cell Biol	137(1)	203-210	1997	WB
13-8300	Ms anti-CX43	Li WEI, et al.	Eur J Neurosci	10	2444-2463	1998	WB, IHC
13-8300	Ms anti-CX43	Martin PE, et al.	J Biol Chem	273(3)	1719-1726	1998	WB
13-8300	Ms anti-CX43	Toyofuku T, et al.	J Biol Chem	273(3)	1519-1528	1998	WB
13-8300	Ms anti-CX43	Bittman KS, et al.	Cerebral Cortex	9	188-195	1999	IF
13-8300	Ms anti-CX43	Nagy JI, et al.	Neuroscience	88(2)	447-468	1999	IF
13-8300	Ms anti-CX43	Xie H, et al.	Neuroscience	88(2)	447-468	1999
13-8300	Ms anti-CX43	Li WEI, Nagy JI.	Neurosci	97 (1)	113-123	2000	WB, iHC
13-8300	Ms anti-CX43	Li WEI, Nagy JI.	Eur J Neurosci	12	2644-2650	2000
33-2500	Ms anti-Cx30	Nagy JI, et al.	Neuroscience	88	447-468	1999
33-2500	Ms anti-Cx30	Nagy JI, et al.	J Comp Neurol	441(4)	302-323	2001	IF (1:500)
33-2500	Ms anti-Cx30	Rash JE, et al.	J Neurosci	21	1983-2000	2001	WB, IHC (froz), Immunogold labeling
33-2500	Ms anti-Cx30	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:500), WB
33-2500	Ms anti-Cx30	Sun J, et al.	Am J Physiol Cell Physiol	288	C613-623	2005	WB (1:1,000), IP, IHC (Ms cochlea, 1:200)
33-2500	Ms anti-Cx30	Jagger DJ, Forge A.	J Neurosci	26(4)	1260-1268	2006	IF (Rt cochlea, 1:200)
33-4300	Ms anti-Cx50	Klepeis VE, et al.	J Cell Sci	114	4185-4195	2001	WB
33-4300	Ms anti-Cx50	Lin D, et al.	Mol Vision	10	688-695	2004	WB, IP (Rt)
33-5800	Ms anti-CX26	Nagy JI, et al.	J Comp Neurol	441	302-323	2001	WB, IF
33-5800	Ms anti-CX26	Rouan F, et al.	J Cell Sci	114	2105-2113	2001	IHC (frozen), WB
33-5800	Ms anti-CX26	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
33-5800	Ms anti-Cx26	Di W-L, et al.	Hum Mol Genet	11	2005-2014	2002	IF (froz, 1:100)
33-5800	Ms anti-CX26	Richard G, et al.	Am J Hum Genet	70	1341-1348	2002	IF
33-5800	Ms anti-Cx26	Aasen T, et al.	Oncogene	22	7969-7980	2003	IF (paraffin)
33-5800	Ms anti-Cx26	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:200), WB
34-4200	Rb anti-Cx29	Li X, et al.	Eur J Neurosci	16	795-806	2002	ICC (froz Ms sciatic nerve), immunogold labeling, WB
34-4200	Rb anti-Cx29	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:400), WB
34-4200	Rb anti-Cx29	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
34-4200	Rb anti-Cx29	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
34-4200	Rb anti-Cx29	Tricaud N, et al.	J Neurosci	25(13)	3259-3269	2005	IHC (Ms sciatic nerve, froz)
34-5700	Rb anti-Connexin 32	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:100), WB
34-5700	Rb anti-Connexin 32	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
34-5700	Rb anti-Connexin 32	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
34-5700	Rb anti-Connexin 32	Zhu L, et al.	Mol Cell Biol	24(7)	2673-2681	2004	IHC (Ms, 1:200)
35-5000	Ms anti-Cx43	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:150), WB
35-5000	Ms anti-Cx43	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
35-5000	Ms anti-Cx43	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
35-5000	Ms anti-Cx43	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB, IF
35-8900	Ms anti-Cx32	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:400), WB
35-8900	Ms anti-Cx32	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
35-8900	Ms anti-Cx32	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB, IF
36-4600	Rb anti-Cx36	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	WB (Ms)
36-4600	Rb anti-Cx36	Rash JE, et al.	J Neurocytol	33	131-152	2004	IHC (Ms, froz), Immunogold labeling
36-4600	Rb anti-Cx36	Lin B, et al.	J Neurosci	25(28)	6696-6701	2005	ICC (Ms retina)
36-4700	Rb anti-CX47	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:400), WB
36-4700	Rb anti-CX47	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
36-4700	Rb anti-Cx47	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB
37-4500	Ms anti-Cx47	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB
37-4600	Ms anti-Cx36	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	IHC (froz, Ms), WB (Ms)
37-4600	Ms anti-Cx36	Rash JE, et al.	J Neurocytol	33	131-152	2004	IHC (Ms, froz)
51-2800	Rb anti-Cx26	Nagy JI, et al.	J Comp Neurol	441	302-323	2001	IF, WB
51-2800	Rb anti-CX26	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
51-2800	Rb anti-CX26	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC, IF
51-2800	Rb anti-Cx26	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:200), WB
51-2800	Rb anti-CX26	Rukstalis JM, et al.	J Cell Sci	116	3315-3325	2003	IHC (Ms, 1:200)
51-2800	Rb anti-Cx26	Teubner B, et al.	Hum Mol Genet	12	13-21	2003	IHC (Ms, froz, 1:100)
51-2800	Rb anti-Cx26	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005	IP, IF (Hu Bx-PC-3)
51-6200	Rb anti-Cx36	Rash JE, et al.	J Neurosci	21	1983-2000	2001	Immunogold labeling
51-6200	Rb anti-Cx36	Yi H, Massey SC.	PNAS	102(37)	13313-13318	2005	ICC (Ms retina, 1:250)
51-6200	Rb anti-Cx36	Rash JE, et al.	PNAS	97(13)	7573-7578	2000
51-6300	Rb anti-Cx36	Rash JE, et al.	J Neurosci	21	1983-2000	2001	Immunogold labeling
51-6300	Rb anti-Cx36	Li X, et al.	Eur J Neurosci	19	2132-2146	2003	WB (Ms), IP
51-6300	Rb anti-Cx36	Pereda A, et al.	J Neurosci	23(20)	7489-7503	2003	Immunogold labeling
51-6300	Rb anti-Cx36	Rash JE, et al.	J Neurocytol	33	131-152	2004	IHC (Ms, froz), Immunogold labeling
51-6300	Rb anti-Cx36	Maxeiner S, et al.	J Neurosci	25(3)	566-576	2005	IHC (Ms retina, PFA-fixed, 1:500)
51-6300	Rb anti-Cx36	Rash JE, et al.	PNAS	97(13)	7573-7578	2000	WB
71-0500	Rb anti-Cx26	Ciray HN, et al.	Am J Obstet Gynecol	182	926-930	2000	IF
71-0500	Rb anti-CX26	Guo Y, et al.	Am J Physiol Lung Cell Mol Physiol	280	191-202	2001	WB
71-0500	Rb anti-Cx26	Nagy JI, et al.	J Comp Neurol	441	302-323	2001	WB, IF
71-0500	Rb anti-CX26	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
71-0500	Rb anti-CX26	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF
71-0500	Rb anti-Cx26	Qin H, et al.	J Biol Chem	277(32)	29132-29138	2002	ICC
71-0500	Rb anti-Cx26	Walcott B, et al.	Am J Physiol Cell Physiol	282	C501-507	2002	ICC (Ms)
71-0500	Rb anti-Cx26	Dufresne J, et al.	Am J Physiol Cell Physiol	284	C33-43	2003	ICC (rat)
71-0500	Rb anti-CX26	El-Sabban ME, et al.	J Cell Sci	116	3531-3541	2003	WB, ICC (Ms)
71-0500	Rb anti-Cx26	Locke D, et al.	Biochemistry	44(39)	13027-13042	2005	ICC, WB
71-0500	Rb anti-Cx26	Kelsell DP, et al.	Nature	387	80-83	1997	IHC (frozen, Hu) 1:100
71-0500	Rb anti-Cx26	Nagy JI, et al.	Neuroscience	78(2)	533-548	1997	WB (1:1000), IHC (frozen) 1:500s
71-0500	Rb anti-Cx26	Bittman KS, et al	Cerebral Cortex	9	188-195	1999	IF
71-0500	Rb anti-Cx26	Nagy JI, et al.	Neuroscience	88(2)	447-468	1999	WB
71-0500	Rb anti-Cx26	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
71-0500	Rb anti-Cx26	Yazulla S, Studholme KM.	J Neurocytology	30	551-592	2001	ICC (Zebrafish 1:100)
71-0600	Rb anti-CX32	Das Sarma J, et al.	J Cell Sci	114	4013-4024	2001	IF
71-0600	Rb anti-CX32	Rash JE, et al.	J Neurosci	21	1983-2000	2001	WB, Immunogold labeling
71-0600	Rb anti-CX32	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
71-0600	Rb anti-CX32	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF
71-0600	Rb anti-CX32	Das Sarma J, et al.	J Biol Chem	277(23)	20911-20918	2002	IF
71-0600	Rb anti-CX32	Govindarajan R, et al.	J Biol Chem	277(51)	50087-50097	2002	ICC
71-0600	Rb anti-Cx32	Walcott B, et al.	Am J Physiol Cell Physiol	282	C501-507	2002	ICC (Ms)
71-0600	Rb anti-Cx32	Dufresne J, et al.	Am J Physiol Cell Physiol	284	C33-43	2003	ICC (rat)
71-0600	Rb anti-CX32	El-Sabban ME, et al.	J Cell Sci	116	3531-3541	2003	WB, ICC (Ms)
71-0600	Rb anti-CX32	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:100), WB
71-0600	Rb anti-CX32	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
71-0600	Rb anti-CX32	Rukstalis JM, et al.	J Cell Sci	116	3315-3325	2003	IHC (Ms, 1:200)
71-0600	Rb anti-Cx32	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (froz, Ms)
71-0600	Rb anti-Cx32	Huang Y, et al.	J Neurosci	25(31)	7111-7120	2005	WB
71-0600	Rb anti-Cx32	Scherer SS, et al.	J Neurosci	25(6)	1550-1559	2005	WB, IHC (Ms nerves, froz, 1:200)
71-0600	Rb anti-CX32	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
71-0600	Rb anti-CX32	Rash JE, et al.	PNAS	97(13)	7573-7578	2000	WB
71-0700	Rb anti-CX43	Beardslee MA, et al.	Circ Res	83	629-635	1998	IF
71-0700	Rb anti-CX43	Li WEI, et al.	Eur J Neurosci	10	2444-2463	1998	WB, IHC
71-0700	Rb anti-CX43	Stregiopoulos K, et al.	Circ Res	84	1144-1155	1999	IP
71-0700	Rb anti-CX43	Beardslee MA, et al.	Circ Res	87	656-662	2000	WB IF
71-0700	Rb anti-CX43	Li WEI, et al.	Neuroscience	97(1)	113-123	2000	WB, IHC
71-0700	Rb anti-CX43	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
71-0700	Rb anti-Cx43	Quist AP, et al.	J Cell Biol	148(5)	1063-1074	2000	IF
71-0700	Rb anti-CX43	Thomas SP, et al.	Circ Res	87	467-473	2000	IF
71-0700	Rb anti-Cx43	Umhauer S, et al.	Am J Obstet Gynecol	182	999-1000	2000	IHC (froz, 1:800)
71-0700	Rb anti-CX43	Bruzzone S, et al.	J Biol Chem	276(51)	48300-48308	2001	WB
71-0700	Rb anti-CX43	De Pina-Benabou MH, et al.	J Neurosci	21(17)	6635-6643	2001	ICC - Ms spinal cord
71-0700	Rb anti-CX43	Guo Y, et al.	Am J Physiol Lung Cell Mol Physiol	280	191-202	2001	WB IF
71-0700	Rb anti-CX43	Oguro K, et al.	J Neurosci	21(19)	7534-7542	2001	WB
71-0700	Rb anti-CX43	Papadaki M, et al.	Am J Phsiol Heart Circ Phys iol	280	168-178	2001	WB
71-0700	Rb anti-CX43	Anderson SC, et al.	Invest Ophthalmol Vis Sci	43	978-986	2002	IHC (Rb cornea, PFA, 1:100)
71-0700	Rb anti-CX43	El-Sabban ME, et al.	Blood	99	3383-3389	2002	WB
71-0700	Rb anti-CX43	Grueterich M, et al.	Invest Ophthalmol Vis Sci	43	63-71	2002	IHC (froz, 1:200)
71-0700	Rb anti-CX43	Li H, et al.	Am J Physiol Heart Circ Phy siol	282	H2124-2133	2002	WB (1:1000), ICC (1:200)
71-0700	Rb anti-Cx43	Pierce BT, et al.	Am J Obstet Gynecol	186	504-511	2002	IHC (Hu, Rt; froz; 1:200)
71-0700	Rb anti-CX43	Plotkin LI, et al.	J Biol Chem	277(10)	8648-8657	2002	WB, IP
71-0700	Rb anti-CX43	Richard G, et al.	Am J Hum Genet	70	1341-1348	2002	IF
71-0700	Rb anti-CX43	Schwanke U, et al.	Am J Physiol Heart Circ Phy siol	283	H1740-1742	2002	WB (Ms)
71-0700	Rb anti-CX43	Abdelmohsen K, et al.	J Biol Chem	278(40)	38360-38367	2003	WB
71-0700	Rb anti-CX43	Carystinos GD, et al.	Mol Pharm	63	821-831	2003	WB
71-0700	Rb anti-CX43	Caton D, et al.	J Cell Sci	116	2285-2294	2003	IF (Rt, 1:500)
71-0700	Rb anti-CX43	El-Sabban ME, et al.	J Cell Sci	116	3531-3541	2003	WB, ICC (Ms)
71-0700	Rb anti-CX43	Guo Y, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1213-1221	2003	ICC (Rt), WB, IP
71-0700	Rb anti-CX43	Lee T-M, Chou T-F.	Am J Physiol Heart Circ Phy siol	285	H1650-1659	2003	WB (Dog)
71-0700	Rb anti-CX43	Luo Y, Radice GL.	J Cell Sci	116	1471-1479	2003	ICC (Ms, PFA-fixed, 1:100)
71-0700	Rb anti-Cx43	Nagy JI, et al.	Glia	44	205-218	2003	WB
71-0700	Rb anti-Cx43	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
71-0700	Rb anti-CX43	Nihei OK, et al.	Am J Physiol Cell Physiol	285	C1304-1313	2003	IF (Ms)
71-0700	Rb anti-CX43	Provost N, et al.	Am J Physiol Cell Physiol	284	C51-59	2003	ICC (1:100), WB
71-0700	Rb anti-CX43	Scheffler B, et al.	Development	130	5533-5541	2003	ICC (Ms brain, pFA-fixed, 1:300)
71-0700	Ms anti-CX43	Simard M, et al.	J Neurosci	23(27)	9254-9262	2003	IHC (Rt, 1:500)
71-0700	Rb anti-CX43	Thomas MA, et al.	J Cell Sci	116	2213-2222	2003	IP, WB
71-0700	Rb anti-CX43	Ye Z-C, et al.	J Neurosci	23(9)	3588-3596	2003	ICC (Rt neurons, 1ug/mL)
71-0700	Rb anti-CX43	Bao X, et al.	J Biol Chem	279(19)	20058-20066	2004	WB
71-0700	Rb anti-CX43	Bao X, et al.	Am J Physiol Cell Physiol	286	C647-654	2004	WB
71-0700	Rb anti-CX43	Forster C, et al.	PNAS	101(39)	14234-14239	2004	IF (Ms, paraffin, 1:100)
71-0700	Rb anti-CX43	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (froz, Ms)
71-0700	Rb anti-CX43	Poelzing S, et al.	Am J Physiol Heart Circ Phy siol	286	H2001-2009	2004	IF (Dog heart, FFPE, citrate, 1:400)
71-0700	Rb anti-CX43	Poelzing S, Rosenbaum DS.	Am J Physiol Heart Circ Phy siol	286	H1762-1780	2004	IF (Dog heart, FFPE, citrate, 1:400)
71-0700	Rb anti-Cx43	Cho WJ, Daniel EE.	Am J Physiol Gastroint Live r Physiol	288	G571-585	2005	Confocal IF (Ms muscle, 1:100)
71-0700	Rb anti-Cx43	Graham C, Simmons NL.	Am J Physiol Regul Integr C omp Physiol	288	R173-181	2005	IF (bovine), WB
71-0700	Rb anti-Cx43	Momose-Sato Y, et al.	J Neurophysiol	94	1606-1622	2005	IHC (Rt, froz, 1:100)
71-0700	Rb anti-Cx43	Peitsch WK, et al.	J Invest Dermatol	125	761-774	2005	IF
71-0700	Rb anti-Cx43	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB, IF
71-0700	Rb anti-Cx43	Betsuyaku T, et al.	Am J Physiol Heart Circ Phy siol	290	H163-171	2006	WB (Ms, 1:5,000), IHC (Ms heart, FFPE, 1:500)
71-2200	Rb anti-CX30	Nagy JI, et al.	Neuroscience	88	447-468	1999	WB, IHC, IF
71-2200	Rb anti-CX30	Nagy JI, et al.	J Comp Neurol	441	302-323	2001	IF (1:100)
71-2200	Rb anti-CX30	Rash JE, et al.	J Neurosci	21	1983-2000	2001	WB, Immunogold labeling
71-2200	Rb anti-Cx30	Di W-L, et al.	Hum Mol Genet	11	2005-2014	2002	IF (froz, 1:100)
71-2200	Rb anti-CX30	Richard G, et al.	Am J Hum Genet	70	1341-1348	2002	IF
71-2200	Rb anti-CX30	Aasen T, et al.	Oncogene	22	7969-7980	2003	IF (paraffin)
71-2200	Rb anti-Cx30	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:100), WB
71-2200	Rb anti-Cx30	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
71-2200	Rb anti-CX30	Teubner B, et al.	Hum Mol Genet	12	13-21	2003	WB
71-2200	Rb anti-CX30	Theis M, et al.	J Neurosci	23(3)	766-776	2003	IF (Ms, 1:500), WB (Ms, 1:250)
71-2200	Rb anti-CX30	Maass K, et al.	Mol Cell Biol	15(10)	4597-4608	2004	IF (Ms, froz)
71-2200	Rb anti-CX30	Thomas T, et al.	J Biol Chem	279(18)	19157-19168	2004	ICC
71-2200	Rb anti-Cx30	McCulloch F, et al.	Am J Physiol Renal Physiol	289	F1304-1312	2005	WB (Rt, 1:250), IF (Rt kidney, 1:50)
71-2200	Rb anti-Cx30	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB (1:1,000), IF
Tight Junction Antibody Product References
32-5600	Ms anti-Claudin-2	Colegio OR, et al.	Am J Physiol Cell Physiol	284	C1346-1354	2003	WB (1:4000)
32-5600	Ms anti-Claudin-2	Coyne CB, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1166-1178	2003	WB
32-9400	Ms anti-Claudin-4	Burgel N, et al.	Gastroenterology	123	433-443	2002	WB
32-9400	Ms anti-Claudin-4	Colegio OR, et al.	Am J Physiol Cell Physiol	283	C142-147	2002	WB (1:4000)
32-9400	Ms anti-Claudin-4	Bonne S, et al.	J Cell Biol	161(2)	403-416	2003	IF (1:1000)
32-9400	Ms anti-Claudin-4	Bruewer M, et al.	J Immunol	171	6164-6172	2003	WB, IF
32-9400	Ms anti-Claudin-4	Colegio OR, et al.	Am J Physiol Cell Physiol	284	C1346-1354	2003	WB (1:4000), IF
32-9400	Ms anti-Claudin-4	Coyne CB, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1166-1178	2003	WB
32-9400	Ms anti-Claudin-4	Mitic LL, et al.	Protein Sci	12	218-227	2003	WB (1:4000)
32-9400	Ms anti-Claudin-4	Rangel LBA, et al.	Clin Cancer Res	9	2567-2575	2003	WB (1:250)
32-9400	Ms anti-Claudin-4	Van Itallie CM, et al.	Am J Physiol Renal Physiol	285	F1078-1084	2003	IF, WB
32-9400	Ms anti-Claudin-4	Yu ASL, et al.	J Biol Chem	278(19)	17350-17359	2003	WB, IF
32-9400	Ms anti-Claudin-4	Acharya P, et al.	Am J Physiol Renal Physiol	287	F305-318	2004	IF
32-9400	Ms anti-Claudin-4	Ivanov AI, et al.	Mol Cell Biol	15(1)	176-188	2004	WB (Hu)
32-9400	Ms anti-Claudin-4	Jones C, et al.	Cancer Res	64(9)	3037-3045	2004	IHC (paraffin, 1:100)
32-9400	Ms anti-Claudin-4	Kahle KT, et al.	PNAS	101(41)	14877-14882	2004	IF (Ms)
32-9400	Ms anti-Claudin-4	Lo D, et al.	Int Immunol	16(1)	91-99	2004	IHC (froz, Hu, Ms)
32-9400	Ms anti-Claudin-4	Matsuda M, et al.	J Cell Sci	117	1247-1257	2004	IF (transfected)
32-9400	Ms anti-Claudin-4	Singh AB, Harris RC.	J Biol Chem	279(5)	3543-3552	2004	WB, IF
32-9400	Ms anti-Claudin-4	Yamauchi K, et al.	PNAS	101	4690-4694	2004	WB
32-9400	Ms anti-Claudin-4	Agarwal R, et al.	Cancer Res	65(16)	7378-7385	2005	WB (verification of gene knockdown)
32-9400	Ms anti-Claudin-4	Carrozzino F, et al.	Am J Physiol Cell Physiol	289	C1002-1014	2005	WB (1ug/mL)
32-9400	Ms anti-Claudin-4	Cross WR, et al.	Am J Physiol Renal Physiol	289	F459-468	2005	Confocal
32-9400	Ms anti-Claudin-4	De Craene B, et al.	Cancer Res	65(14)	6237-6244	2005	IF/ICC
32-9400	Ms anti-Claudin-4	D'Souza T, et al.	J Biol Chem	280(28)	26233-26240	2005	WB (1:250), IP
32-9400	Ms anti-Claudin-4	Le Moellic C, et al.	Am J Physiol Cell Physiol	289	C1513-1521	2005	IF (1:50), IP (1:40), WB (1:1,000)
32-9400	Ms anti-Claudin-4	Lipschutz J, et al.	J Biol Chem	280(5)	3780-3788	2005	WB (1:200), IF (MDCK, 1:500)
32-9400	Ms anti-Claudin-4	Prasad S, et al.	Lab Invest	85	1139-1162	2005	IHC (Hu, 1:400), IF (1:400), WB
32-9400	Ms anti-Claudin-4	Santin AD, et al.	Cancer Res	65(10)	4334-4342	2005	IHC (FFPE, Hu ovarian tumors, citrate)
32-9400	Ms anti-Claudin-4	Shlyonsky V, et al.	J Biol Chem	280(25)	24181-24187	2005	ICC
32-9400	Ms anti-Claudin-4	Weng X-H, et al.	Am J Physiol Gastrointest Li ver Physiol	288	G705-717	2005	IF (dog intestine, 1:2,000), WB (DIEC)
32-9400	Ms anti-Claudin-4	Yu ASL, et al.	Am J Physiol Cell Physiol	288	C1231-1241	2005	WB
32-9800	Ms anti-Claudin-15	Colegio OR, et al.	Am J Physiol Cell Physiol	283	C142-147	2002	WB (1:2000), IF (1:100)
32-9800	Ms anti-Claudin-15	Coyne CB, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1166-1178	2003	WB
32-9800	Ms anti-Claudin-15	Van Itallie CM, et al.	Am J Physiol Renal Physiol	285	F1078-1084	2003	IF, WB
33-1500	Ms anti-Occludin	Clarke H, et al.	J Cell Sci	113	3187-3196	2000	IF
33-1500	Ms anti-Occludin	Kevil CG, et al.	Am J Physiol Cell Physiol	279	C21-30	2000	IF (1:250), WB
33-1500	Ms anti-Occludin	Mohammad-Panah, et al.	J Biol Chem	276(11)	8306-8313	2001	IF
33-1500	Ms anti-Occludin	Notterpek L, et al.	PNAS	98(25)	14404-14409	2001	IHC, WB
33-1500	Ms anti-Occludin	Singh U, et al.	J Biol Chem	276(36)	33402-33412	2001	IF
33-1500	Ms anti-Occludin	Van Itallie C, et al.	J Clin Invest	107	1319-1327	2001	WB
33-1500	Ms anti-Occludin	Amasheh S, et al.	J Cell Sci	115	4969-4976	2002	IF
33-1500	Ms anti-Occludin	Gudjonsson T, et al.	Genes Dev	16(6)	693-706	2002	ICC
33-1500	Ms anti-Occludin	Lemmers C, et al.	J Biol Chem	277(28)	25408-25415	2002	ICC
33-1500	Ms anti-Occludin	Nunbhakdi-Craig V, et al.	J Cell Biol	158(5)	967-978	2002	WB, IF
33-1500	Ms anti-Occludin	Basuroy S, et al.	J Biol Chem	278(14)	11916-11924	2003	IF
33-1500	Ms anti-Occludin	Colegio OR, et al.	Am J Physiol Cell Physiol	284	C1346-1354	2003	WB (1:1500)
33-1500	Ms anti-Occludin	Rafiee P, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G1277-1292	2003	IF (Hu)
33-1500	Ms anti-Occludin	Taouil K, et al.	J Biol Chem	278(19)	17320-17327	2003	IF
33-1500	Ms anti-Occludin	Witt KA, et al.	Am J Physiol Heart Circ Phy siol	285	H2820-2831	2003	WB (Rt)
33-1500	Ms anti-Occludin	Yoo J, et al.	Am J Physiol Cell Physiol	285	C300-309	2003	IP
33-1500	Ms anti-Occludin	Yu ASL, et al.	J Biol Chem	278(19)	17350-17359	2003	WB, IF
33-1500	Ms anti-Occludin	Badizadegan K, et al.	Am J Physiol Cell Physiol	287	C1453-1462	2004
33-1500	Ms anti-Occludin	Banan A, et al.	Am J Physiol Cell Physiol	287	C218-234	2004	IF
33-1500	Ms anti-Occludin	Kahle KT, et al.	PNAS	101(41)	14877-14882	2004	IF (Ms)
33-1500	Ms anti-Occludin	Lemmers C, et al.	Mol Cell Biol	15(3)	1324-1333	2004	IF (1:200)
33-1500	Ms anti-Occludin	McLaughlin J, et al.	Am J Physiol Cell Physiol	287	C1412-1417	2004
33-1500	Ms anti-Occludin	Sajjan U, et al.	Infect Immun	72	4188-4199	2004	WB (Hu, 1:250)
33-1500	Ms anti-Occludin	Seth A, et al.	Am J Physiol Gastroint Live r Physiol	287	G510-517	2004
33-1500	Ms anti-Occludin	Smith MS, et al.	J Virol	78	4444-4453	2004	WB (Hu)
33-1500	Ms anti-Occludin	Basuroy S, et al.	Am J Physiol Gastrointest Li ver Physiol	289	G367-375	2005	Confocal IF (Hu)
33-1500	Ms anti-Occludin	Jacob C, et al.	J Biol Chem	280(36)	31936-31948	2005	WB, IF (T84 cells)
33-1500	Ms anti-Occludin	Mottino AD, et al.	Am J Physiol Gastrointest Li ver Physiol	288	G327-336	2005	IF (1:100)
33-1500	Ms anti-Occludin	Polette M, et al.	Cancer Res	65(17)	7691-7698	2005	IF, WB (MCF-7, BT549 cells)
33-1500	Ms anti-Occludin	Shifflett DE, et al.	Lab Invest	85	1308-1324	2005	IHC (Ms, froz, 0.5ug/mL), WB
33-1500	Ms anti-Occludin	Wang G, et al.	PNAS	102(1)	186-191	2005	ICC, FC
33-1500	Ms anti-Occludin	Weng X-H, et al.	Am J Physiol Gastroint Live r Physiol	288	G705-717	2005	IF (dog intestine, 1:1,000), WB (DIEC)
33-1500	Ms anti-Occludin	Chen X, Macara IG.	J Cell Biol	172	671-678	2006	IF
33-1500	Ms anti-Occludin	Potempa S, et al.	Mol Biol Cell	9	2185-2200	1998	IF
33-1500	Ms anti-Occludin	Berglund JJ, et al.	Am J Physiol Gastroint Live r Physiol	281	G1487-G149 3	2001	IF
33-1511	FITC-Ms anti-Occludin	Choe MM, et al.	Am J Physiol Lung Cell Mol Physiol	285	L427-433	2003	IF
33-1511	FITC-Ms anti-Occludin	Parkinson SJ, et al.	EMBO J	23	77-88	2004	IF
33-9100	Ms anti-ZO-1	Boettner B, et al.	PNAS	97(16)	9064-9069	2000	IF
33-9100	Ms anti-ZO-1	Cohen CJ, et al.	PNAS	98(26)	15191-15196	2001	IF
33-9100	Ms anti-ZO-1	Naishiro Y, et al.	Cancer Res	61	2751-2758	2001	WB
33-9100	Ms anti-ZO-1	Notterpek L, et al.	PNAS	98(25)	14404-14409	2001	WB, IHC
33-9100	Ms anti-ZO-1	Singh U, et al.	J Biol Chem	276(36)	33402-33412	2001	IF
33-9100	Ms anti-ZO-1	Van Itallie C, et al.	J Clin Invest	107	1319-1327	2001	WB, IF
33-9100	Ms anti-ZO-1	Cooper CD, Lampe PD.	J Biol Chem	277(47)	44962-44968	2002	WB, IF
33-9100	Ms anti-ZO-1	Nishimura M, et al.	J Biol Chem	277(7)	5583-5587	2002	IF
33-9100	Ms anti-ZO-1	Patrie KM, et al.	J Biol Chem	277(33)	30183-30190	2002	IF
33-9100	Ms anti-ZO-1	Ranaldi G, et al.	Am J Physiol Renal Physiol	283	F1365-1375	2002	IF
33-9100	Ms anti-ZO-1	Roh MH, et al.	J Cell Biol	157(1)	161-172	2002	ICC (1:2000), IHC (froz, rat)
33-9100	Ms anti-ZO-1	Roh MH, et al.	J Biol Chem	277(30)	27501-27509	2002	ICC
33-9100	Ms anti-ZO-1	Anders M, et al.	Cancer Res	63	2088-2095	2003	WB, IF
33-9100	Ms anti-ZO-1	Colegio OR, et al.	Am J Physiol Cell Physiol	284	C1346-1354	2003	WB (1:1500)
33-9100	Ms anti-ZO-1	Gentzsch M, et al.	J Biol Chem	278(8)	6440-6449	2003	IF
33-9100	Ms anti-ZO-1	Gutstein DE, et al.	J Cell Sci	116	875-885	2003	WB, IF (Ms heart, froz)
33-9100	Ms anti-ZO-1	Hirabayashi S, et al.	Mol Cell Biol	23	4267-4282	2003	IF (Rt)
33-9100	Ms anti-ZO-1	Hurd TW, et al.	Nature Cell Biol	5	137-142	2003
33-9100	Ms anti-ZO-1	Kominsky SL, et al.	Oncogene	22	2021-2033	2003	IF
33-9100	Ms anti-ZO-1	Lu Z, et al,	Cancer Cell	4(6)	499-515	2003
33-9100	Ms anti-ZO-1	Narayan S, et al.	Invest Ophthalmol Vis Sci	44	4885-4894	2003	WB, IF
33-9100	Ms anti-ZO-1	Neunlist M, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G1028-1036	2003	IF (Hu, 1:500), WB (1:1,000)
33-9100	Ms anti-ZO-1	Rafiee P, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G1277-1292	2003	IF (Hu)
33-9100	Ms anti-ZO-1	Roh MH, et al.	J Cell Sci	116	2895-2906	2003	ICC
33-9100	Ms anti-ZO-1	Silvis MR, et al.	J Biol Chem	278(13)	11554-11560	2003	IF
33-9100	Ms anti-ZO-1	Witt KA, et al.	Am J Physiol Heart Circ Phy siol	285	H2820-2831	2003	WB (Rt)
33-9100	Ms anti-ZO-1	Young P, et al.	EMBO J	22	5723-5733	2003	IHC (Ms, PFA_fixed, paraffin)
33-9100	Ms anti-ZO-1	Yu ASL, et al.	J Biol Chem	278(19)	17350-17359	2003	WB, IF
33-9100	Ms anti-ZO-1	Badizadegan K, et al.	Am J Physiol Cell Physiol	287	C1453-1462	2004
33-9100	Ms anti-ZO-1	Clayburgh DR, et al.	J Biol Chem	279(53)	55506-55513	2004	IF (Hu, 2.5 ug/mL)
33-9100	Ms anti-ZO-1	Coyne CB, et al.	J Biol Chem	279(46)	48079-48084	2004	WB, IF
33-9100	Ms anti-ZO-1	Estienne V, et al.	Am J Physiol Cell Physiol	287	C1763-1768	2004
33-9100	Ms anti-ZO-1	Kahle KT, et al.	PNAS	101(41)	14877-14882	2004	IF (Ms)
33-9100	Ms anti-ZO-1	Kizhatil K, Bennett V.	J Biol Chem	279(16)	16706-16714	2004	IF
33-9100	Ms anti-ZO-1	Li WY, et al.	Am J Physiol Renal Physiol	286	F1063-1071	2004	IF (Ms kidney, froz, 1:100)
33-9100	Ms anti-ZO-1	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	IP (Ms)
33-9100	Ms anti-ZO-1	Liu X-F, et al.	Mol Cell Biol	24(15)	6665-6675	2004	IF (Dog, 1:500)
33-9100	Ms anti-ZO-1	McLaughlin J, et al.	Am J Physiol Cell Physiol	287	C1412-1417	2004
33-9100	Ms anti-ZO-1	Mohler PJ, et al.	PNAS	101(50)	17533-17538	2004	IF (Rt)
33-9100	Ms anti-ZO-1	Parker LH, et al.	Nature	428	754-758	2004	IF
33-9100	Ms anti-ZO-1	Sajjan U, et al.	Infect Immun	72	4188-4199	2004
33-9100	Ms anti-ZO-1	Smith MS, et al.	J Virol	78	4444-4453	2004	WB (Hu)
33-9100	Ms anti-ZO-1	Bagnoli F, et al.	PNAS	102(45)	16339-16344	2005	IF
33-9100	Ms anti-ZO-1	Bratt A, et al.	J Biol Chem	280(41)	34859-34869	2005	IF (Bv, Ms)
33-9100	Ms anti-ZO-1	Brooks TA, et al.	Am J Physiol Heart Circ Phy siol	289	H738-743	2005
33-9100	Ms anti-ZO-1	Caruso-Neves C, et al.	PNAS	102(48)	17513-17518	2005	IF (pig LLC-PK1 cells)
33-9100	Ms anti-ZO-1	Cross WR, et al.	Am J Physiol Renal Physiol	289	F459-468	2005	Confocal
33-9100	Ms anti-ZO-1	Furuya M, et al.	Cancer Res	65(7)	2617-2625	2005	IF (Hu HTOA cells)
33-9100	Ms anti-ZO-1	Graham C, Simmons NL.	Am J Physiol Regul Integr C omp Physiol	288	R173-181	2005	IF (bovine)
33-9100	Ms anti-ZO-1	Guerra L, et al.	J Biol Chem	280(49)	40925-40933	2005	Confocal IF
33-9100	Ms anti-ZO-1	Lipschutz J, et al.	J Biol Chem	280(5)	3780-3788	2005	WB (1:500), IF (MDCK, 1:100)
33-9100	Ms anti-ZO-1	Lopez C, et al.	J Biol Chem	280(9)	8221-8228	2005	IF (4ug/mL, MDCK)
33-9100	Ms anti-ZO-1	Mandell KJ, et al.	J Biol Chem	280	11665-11674	2005	WB
33-9100	Ms anti-ZO-1	Masuda M, et al.	J Biol Chem	280(51)	42164-42171	2005	IF
33-9100	Ms anti-ZO-1	Navarro C, et al.	Oncogene	24	4330-4339	2005	IF, confocal imaging (MDCK)
33-9100	Ms anti-ZO-1	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	IP, IF, WB
33-9100	Ms anti-ZO-1	Polette M, et al.	Cancer Res	65(17)	7691-7698	2005	IF, confocal (MCF-7, BT549 cells), WB, IHC (FFPE invasive breast ductal carcinoma)
33-9100	Ms anti-ZO-1	Prasad S, et al.	Lab Invest	85	1139-1162	2005	IF (1:250)
33-9100	Ms anti-ZO-1	Shin K, et al.	J Cell Biol	168(5)	705-711	2005	IF (MDCKII)
33-9100	Ms anti-ZO-1	Wang Y, et al.	Am J Physiol Renal Physiol	289	F850-862	2005	IF (pig LLC-PK1 cells)
33-9100	Ms anti-ZO-1	Wei C-J, et al.	J Biol Chem	280(20)	19925-19936	2005	ICC
33-9100	Ms anti-ZO-1	Wittchen ES, et al.	J Biol Chem	280(12)	11675-11682	2005	IF
33-9100	Ms anti-ZO-1	Yoshii T, et al.	Am J Physiol Gastroint Live r Physiol	288	G564-570	2005	IF
33-9100	Ms anti-ZO-1	Harita Y, et al.	Am J Physiol Renal Physiol	290	F335-344	2006	IF (Rt kidney, froz)
33-9111	Ms anti-ZO-1-FITC	Cummins CL, et al.	Pharm Res	18(8)	1102-1109	2001	IF
33-9111	Ms anti-ZO-1-FITC	Wong C-H, et al.	J Cell Sci	117	783-798	2004	IF (Rt testes, froz. 1:100)
33-9111	Ms anti-ZO-1-FITC	Bandyopadhyay BC, et al.	J Biol Chem	280(13)	12908-12916	2005	IF (MDCK, 1:100)
34-1600	Rb anti-Claudin-5	Burgel N, et al.	Gastroenterology	123	433-443	2002	WB
34-1600	Rb anti-Claudin-5	Coyne CB, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1166-1178	2003	WB, IF
34-1600	Rb anti-Claudin-5	Wadham C, et al.	Mol Biol Cell	14(6)	2520-2529	2003	IHC (Ms, froz)
34-1600	Rb anti-Claudin-5	Yoo J, et al.	Am J Physiol Cell Physiol	285	C300-309	2003	WB
34-1600	Rb anti-Claudin-5	Barmeyer C, et al.	Am J Physiol Gastrointest Li ver Physiol	286	G244-252	2004	WB (Ms)
34-1600	Rb anti-Claudin-5	Rahner C, et al.	J Cell Sci	117	3307-3318	2004	IF (Ck retina)
34-1600	Rb anti-Claudin-5	Brooks TA, et al.	Am J Physiol Heart Circ Phy siol	289	H738-743	2005
34-1600	Rb anti-Claudin-5	Weng X-H, et al.	Am J Physiol Gastrointest Li ver Physiol	288	G705-717	2005	If (dog intestine, 1:2,000)
34-1600	Rb anti-Claudin-5	Jacquillet G, et al.	Am J Physiol Renal Physiol	290	F127-137	2006	IF (froz Rt kidney, 20 ug/mL)
34-1700	Rb anti-Claudin-3	Amasheh S, et al.	J Cell Sci	115	4969-4976	2002	IF
34-1700	Rb anti-Claudin-3	Burgel N, et al.	Gastroenterology	123	433-443	2002	WB
34-1700	Rb anti-Claudin-3	Coyne CB, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1166-1178	2003	WB, IF
34-1700	Rb anti-Claudin-3	Ikenouchi J, et al.	J Cell Sci	116	1959-1967	2003	WB, IF
34-1700	Rb anti-Claudin-3	Rangel LBA, et al.	Clin Cancer Res	9	2567-2575	2003	WB (1:200)
34-1700	Rb anti-Claudin-3	Witt KA, et al.	Am J Physiol Heart Circ Phy siol	285	H2820-2831	2003	WB (Rt)
34-1700	Rb anti-Claudin-3	Wolburg H, et al.	Acta Neuropathol	105	586-592	2003	IF, WB (mouse)
34-1700	Rb anti-Claudin-3	Yoo J, et al.	Am J Physiol Cell Physiol	285	C300-309	2003	WB
34-1700	Rb anti-Claudin-3	Yu ASL, et al.	J Biol Chem	278(19)	17350-17359	2003	WB, IF
34-1700	Rb anti-Claudin-3	Barmeyer C, et al.	Am J Physiol Gastrointest Li ver Physiol	286	G244-252	2004	WB (Ms)
34-1700	Rb anti-Claudin-3	Kahle KT, et al.	PNAS	101(41)	14877-14882	2004	IF (Ms)
34-1700	Rb anti-Claudin-3	Matsuda M, et al.	J Cell Sci	117	1247-1257	2004	IF (transfected)
34-1700	Rb anti-Claudin-3	Singh AB, Harris RC.	J Biol Chem	279(5)	3543-3552	2004	WB, IF
34-1700	Rb anti-Claudin-3	Yamauchi K, et al.	PNAS	101	4690-4694	2004	WB
34-1700	Rb anti-Claudin-3	Agarwal R, et al.	Cancer Res	65(16)	7378-7385	2005	WB (verification of gene knockdown)
34-1700	Rb anti-Claudin-3	Brooks TA, et al.	Am J Physiol Heart Circ Phy siol	289	H738-743	2005
34-1700	Rb anti-Claudin-3	Carrozzino F, et al.	Am J Physiol Cell Physiol	289	C1002-1014	2005	WB (1ug/mL)
34-1700	Rb anti-Claudin-3	D'Souza T, et al.	J Biol Chem	280(28)	26233-26240	2005	WB (1:200), IHC (Hu ovary, ovarian cancer), IF (1:100)
34-1700	Rb anti-Claudin-3	Guo X, et al.	Am J Physiol Gastroint Live r Physiol	288	G1159-1169	2005	WB
34-1700	Rb anti-Claudin-3	Lipschutz J, et al.	J Biol Chem	280	3780-3788	2005	WB, IF (MDCK, 1:500)
34-1700	Rb anti-Claudin-3	Meng J, et al.	PNAS	102(46)	16696-16700	2005	IF (Ms testis, paraffin), WB
34-1700	Rb anti-Claudin-3	Prasad S, et al.	Lab Invest	85	1139-1162	2005	IHC (Hu, 1:50), IF (1:200), WB
34-1700	Rb anti-Claudin-3	Weng X-H, et al.	Am J Physiol Gastroint Live r Physiol	288	G705-717	2005	IF (dog intestine, 1:1,000), WB (DIEC)
34-1700	Rb anti-Claudin-3	Xu H, et al.	Invest Ophthalmol Vis Sci	46	2487-2494	2005	WB
34-1700	Rb anti-Claudin-3	Yu ASL, et al.	Am J Physiol Cell Physiol	288	C1231-1241	2005	WB
34-1700	Rb anti-Claudin-3	Jacquillet G, et al.	Am J Physiol Renal Physiol	290	F127-137	2006	IF (froz Rt kidney, 5 ug/mL)
34-5400	Rb anti-Claudin-16	Coyne CB, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1166-1178	2003	WB
34-9100	Rb anti-Claudin-7	Kominsky SL, et al.	Oncogene	22(13)	2021-2033	2003	IHC, IF
34-9100	Rb anti-Claudin-7	Li WY, et al.	Am J Physiol Renal Physiol	286	F1063-1071	2004	WB (1:1,000), IF (Ms kidney, froz, 1:5,000)
34-9100	Rb anti-Claudin-7	Carrozzino F, et al.	Am J Physiol Cell Physiol	289	C1002-1014	2005	WB (1ug/mL)
34-9100	Rb anti-Claudin-7	Lipschutz J, et al.	J Biol Chem	280	3780-3788	2005	IF (MDCK, 1:500)
34-9100	Rb anti-Claudin-7	Yu ASL, et al.	Am J Physiol Cell Physiol	299	C1231-1241	2005	WB
35-2500	Ms anti-Claudin-5	Poliak S, et al.	J Cell Biol	159(2)	361-371	2002	IF
35-2500	Ms anti-Claudin-5	Rahner C, et al.	J Cell Sci	117	3307-3318	2004	IF (Ck retina)
35-2500	Ms anti-Claudin-5	Weng X-H, et al.	Am J Physiol Gastrointest Li ver Physiol	288	G705-717	2005	IF (dog intestine, 1:1,000)
35-2500	Ms anti-Claudin-5	Musch MW, et al.	Am J Physiol Gastrointest Li ver Physiol	290	G222-231	2006	Confocal IF (Caco-2), WB
36-1700	Rb anti-JAM-A	Ivanov AI, et al.	Mol Cell Biol	15(1)	176-188	2004	IF (Hu), WB
36-1700	Rb anti-JAM-A	Ivanov AI, et al.	Mol Cell Biol	15(6)	2639-2651	2004	IF (Hu)
36-1700	Rb anti-JAM-A	Mandell KJ, et al.	J Biol Chem	280	11665-11674	2005	WB, IF
36-1700	Rb anti-JAM-A	Mertens AEE, et al.	J Cell Biol	170(7)	1029-1037	2005	WB, IF (Ms)
36-1700	Rb anti-JAM-A	Yu ASL, et al.	Am J Physiol Cell Physiol	288	C1231-1241	2005	WB
36-4000	Rb anti-ZO-3	Li X, et al.	Neuroscience	126	611-630	2004
36-4500	Rb anti-Claudin-11/OSP	Acharya P, et al.	Am J Physiol Renal Physiol	287	F305-318	2004	IF
36-4500	Rb anti-Claudin-11/OSP	Meng J, et al.	PNAS	102(46)	16696-16700	2005	IF (Ms testis, paraffin)
36-4800	Rb anti-Claudin-4	Van Itallie C, et al	J Clin Invest	107(10)	1319-27	2001	IF (1:100) human
36-4800	Rb anti-Claudin-4	Guo X, et al.	Am J Physiol Cell Physiol	285	C1174-1187	2003	WB (Rt)
37-4900	Ms anti-Claudin-1	Jacob C, et al.	J Biol Chem	280(36)	31936-31948	2005	WB, IF (T84 cells)
38-8000	Rb anti-Claudin-18 (Ms)	Gon Y, et al.	PNAS	102(26)	9270-9275	2005	IHC (Ms lung, PFA-fixed, froz)
40-2200	Rb anti-ZO-1 (Mid)	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	IF
40-2300	Rb anti-ZO-1 (N-term)	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	IF
40-2800	Rb anti-ZONAB	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	IF, WB
51-6100	Rb anti-Claudin-2	Nishiyama R, et al.	J Biol Chem	276(38)	35571-35580	2001	IHC, Blot Hybridization
51-6100	Rb anti-Claudin-2	Amasheh S, et al.	J Cell Sci	115	4969-4976	2002	IF
51-6100	Rb anti-Claudin-2	Burgel N, et al.	Gastroenterology	123	433-443	2002	WB
51-6100	Rb anti-Claudin-2	Poliak S, et al.	J Cell Biol	159(2)	361-371	2002	IF (Ms sciatic nerve)
51-6100	Rb anti-Claudin-2	Sakaguchi T, et al.	J Biol Chem	277(24)	21361-21370	2002	IF, IHC (Ms, frozen)
51-6100	Rb anti-Claudin-2	Turksen K, Troy T-C.	Development	129	1775-1784	2002	IHC (Ms skin, paraffin, 1:100)
51-6100	Rb anti-Claudin-2	Guo X, et al.	Am J Physiol Cell Physiol	285	C1174-1187	2003
51-6100	Rb anti-Claudin-2	Kansagra K, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G1162-1170	2003	WB (Pig, 1:500)
51-6100	Rb anti-Claudin-2	Leung LW, et al.	Am J Physiol Cell Physiol	284	C1021-1030	2003	WB
51-6100	Rb anti-Claudin-2	Van Itallie CM, et al.	Am J Physiol Renal Physiol	285	F1078-1084	2003	IF, WB
51-6100	Rb anti-Claudin-2	Yoo J, et al.	Am J Physiol Cell Physiol	285	C300-309	2003	WB
51-6100	Rb anti-Claudin-2	Yu ASL, et al.	J Biol Chem	278(19)	17350-17359	2003	WB, IF
51-6100	Rb anti-Claudin-2	Acharya P, et al.	Am J Physiol Renal Physiol	287	F305-318	2004
51-6100	Rb anti-Claudin-2	Balkovetz DF, et al.	Am J Physiol Renal Physiol	286	F702-710	2004	WB (MDCK II, 1:250)
51-6100	Rb anti-Claudin-2	Barmeyer C, et al.	Am J Physiol Gastrointest Li ver Physiol	286	G244-252	2004	WB (Ms)
51-6100	Rb anti-Claudin-2	Bojarski C, et al.	J Cell Sci	117	2097-2107	2004	WB (Hu)
51-6100	Rb anti-Claudin-2	Kahle KT, et al.	PNAS	101(41)	14877-14882	2004	IF (Ms)
51-6100	Rb anti-Claudin-2	Luton F, et al.	Mol Cell Biol	15(3)	1134-1145	2004	WB
51-6100	Rb anti-Claudin-2	McLaughlin J, et al.	Am J Physiol Cell Physiol	287	C1412-1417	2004
51-6100	Rb anti-Claudin-2	Singh AB, Harris RC.	J Biol Chem	279(5)	3543-3552	2004	WB, IF
51-6100	Rb anti-Claudin-2	Yeaman C, et al.	J Cell Sci	117	559-570	2004	IP, WB
51-6100	Rb anti-Claudin-2	Carrozzino F, et al.	Am J Physiol Cell Physiol	289	C1002-1014	2005	WB (0.5 ug/mL)
51-6100	Rb anti-Claudin-2	Chung E, et al.	J Invest Dermatol	124	1134-1140	2005	WB
51-6100	Rb anti-Claudin-2	Cross WR, et al.	Am J Physiol Renal Physiol	289	F459-468	2005	Confocal
51-6100	Rb anti-Claudin-2	Guo X, et al.	Am J Physiol Gastroint Live r Physiol	288	G1159-1169	2005	WB
51-6100	Rb anti-Claudin-2	Lipschutz J, et al.	J Biol Chem	280(5)	3780-3788	2005	IF (MDCK, 1:500), WB (1:250)
51-6100	Rb anti-Claudin-2	Prasad S, et al.	Lab Invest	85	1139-1162	2005	IHC (Hu, 1:40), IF (1:150), WB
51-6100	Rb anti-Claudin-2	Weng X-H, et al.	Am J Physiol Gastroint Live r Physiol	288	G705-717	2005	IF (dog intestine, 1:1,000)
51-6100	Rb anti-Claudin-2	Yu ASL, et al.	Am J Physiol Cell Physiol	288	C1231-1241	2005	WB
51-6100	Rb anti-Claudin-2	Jacquillet G, et al.	Am J Physiol Renal Physiol	290	F127-137	2006	IF (froz Rt kidney, 1ug/mL)
51-9000	Rb anti-Claudin-1	McCarthy KM, et al.	J Cell Sci	113	3387-3398	2000	WB IF
51-9000	Rb anti-Claudin-1	Troxell ML, et al.	J Cell Sci	113	985-996	2000	WB IF
51-9000	Rb anti-Claudin-1	Huber JD, et al.	Am J Physiol Heart Circ Phy siol	280	1241-1248	2001	WB
51-9000	Rb anti-Claudin-1	Kawabe H et al.	J Biol Chem	276(51)	48350-48355	2001	IF
51-9000	Rb anti-Claudin-1	Kucharzik T, et al.	Am J Pathol	159(6)	2001-2009	2001	IF, WB, IHC (FFPE) ventana ES
51-9000	Rb anti-Claudin-1	Miyamori H, et al.	J Biol Chem	276(30)	28204-28211	2001	IP, IF
51-9000	Rb anti-Claudin-1	Nishiyama R, et al.	J Biol Chem	276(38)	35571-35580	2001	IHC (Paraform fix), Blot Hybridization
51-9000	Rb anti-Claudin-1	Notterpek L, et al.	PNAS	98(25)	14404-14409	2001	IHC
51-9000	Rb anti-Claudin-1	Amasheh S, et al.	J Cell Sci	115	4969-4976	2002	IF
51-9000	Rb anti-Claudin-1	Burgel N, et al.	Gastroenterology	123	433-443	2002	WB
51-9000	Rb anti-Claudin-1	Chen ML, et al.	J Biol Chem	277(6)	4247-4254	2002
51-9000	Rb anti-Claudin-1	Jin M, et al.	Invest Ophthalmol Vis Sci	43	2782-2790	2002	IF
51-9000	Rb anti-Claudin-1	Poliak S, et al.	J Cell Biol	159(2)	361-371	2002	IF (Ms sciatic nerve)
51-9000	Rb anti-Claudin-1	Traweger A et al.	J Biol Chem	277(12)	10201-10208	2002	IF WB
51-9000	Rb anti-Claudin-1	Colegio OR, et al.	Am J Physiol Cell Physiol	284	C1346-1354	2003	WB (1:3000)
51-9000	Rb anti-Claudin-1	Coyne CB, et al.	J Pharmacol Exp Ther	305(2)	440-450	2003	IF (1:1000)
51-9000	Rb anti-Claudin-1	Coyne CB, et al.	Am J Physiol Lung Cell Mol Physiol	285	L1166-1178	2003	WB, IF
51-9000	Rb anti-Claudin-1	Kansagra K, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G1162-1170	2003	WB (Pig, 1:250)
51-9000	Rb anti-Claudin-1	Lee S-W, et al.	Nature Medicine	9(7)	900-906	2003	WB
51-9000	Rb anti-Claudin-1	Leung LW, et al.	Am J Physiol Cell Physiol	284	C1021-1030	2003	WB
51-9000	Rb anti-Claudin-1	McDermott JR, et al.	PNAS	100(13)	7761-7766	2003	IHC (froz, Ms)
51-9000	Rb anti-Claudin-1	Meyer TN, et al.	Am J Physiol Cell Physiol	285	C1281-1293	2003	IP, WB
51-9000	Rb anti-Claudin-1	Rafiee P, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G1277-1292	2003	IF (Hu)
51-9000	Rb anti-Claudin-1	Rangel LBA, et al.	Clin Cancer Res	9	2567-2575	2003	WB (1:200)
51-9000	Rb anti-Claudin-1	Traweger A, et al.	J Biol Chem	278(4)	2692-2700	2003	IF
51-9000	Rb anti-Claudin-1	Van Itallie CM, et al.	Am J Physiol Renal Physiol	285	F1078-1084	2003	WB
51-9000	Rb anti-Claudin-1	Wolburg H, et al.	Acta Neuropathol	105	586-592	2003	IF, WB (mouse)
51-9000	Rb anti-Claudin-1	Yoo J, et al.	Am J Physiol Cell Physiol	285	C300-309	2003	WB
51-9000	Rb anti-Claudin-1	Yu ASL, et al.	J Biol Chem	278(19)	17350-17359	2003	WB, IF
51-9000	Rb anti-Claudin-1	Barmeyer C, et al.	Am J Physiol Gastrointest Li ver Physiol	286	G244-252	2004	WB (Ms)
51-9000	Rb anti-Claudin-1	Bojarski C, et al.	J Cell Sci	117	2097-2107	2004	WB (Dog, Hu)
51-9000	Rb anti-Claudin-1	Epple HJ, et al.	Infect Immun	72	4848-4858	2004
51-9000	Rb anti-Claudin-1	Gao L, Macara IG.	J Biol Chem	279(40)	41557-41562	2004	IF (1:50)
51-9000	Rb anti-Claudin-1	Han X, et al.	Am J Physiol Gastroint Live r Physiol	286	126-136	2004	IF (Ms)
51-9000	Rb anti-Claudin-1	Ivanov AI, et al.	Mol Cell Biol	15(1)	176-188	2004	IF (Hu)
51-9000	Rb anti-Claudin-1	Kahle KT, et al.	PNAS	101(41)	14877-14882	2004	IF (Ms)
51-9000	Rb anti-Claudin-1	Lee DBN, et al.	Am J Physiol Renal Physiol	287	F481-491	2004
51-9000	Rb anti-Claudin-1	McLaughlin J, et al.	Am J Physiol Cell Physiol	287	C1412-1417	2004
51-9000	Rb anti-Claudin-1	Singh AB, Harris RC.	J Biol Chem	279(5)	3543-3552	2004	WB, IF
51-9000	Rb anti-Claudin-1	Wang X, et al.	J Cell Sci	117	53-62	2004	IHC (Ms, froz)
51-9000	Rb anti-Claudin-1	Yeaman C, et al.	J Cell Sci	117	559-570	2004	IP, WB
51-9000	Rb anti-Claudin-1	Brooks TA, et al.	Am J Physiol Heart Circ Phy siol	289	H738-743	2005
51-9000	Rb anti-Claudin-1	Carrozzino F, et al.	Am J Physiol Cell Physiol	289	C1002-1014	2005	WB (1ug/mL)
51-9000	Rb anti-Claudin-1	Chung E, et al.	J Invest Dermatol	124	1134-1140	2005	WB
51-9000	Rb anti-Claudin-1	Cross WR, et al.	Am J Physiol Renal Physiol	289	F459-468	2005	Confocal
51-9000	Rb anti-Claudin-1	Graham C, Simmons NL.	Am J Physiol Regul Integr C omp Physiol	288	R173-181	2005	IF (bovine), WB
51-9000	Rb anti-Claudin-1	Leyvraz C, et al.	J Cell Biol	170(3)	487-496	2005	IF (Ms skin)
51-9000	Rb anti-Claudin-1	Lipschutz J, et al.	J Biol Chem	280(5)	3780-3788	2005	WB (1:250)
51-9000	Rb anti-Claudin-1	Meder D, et al.	J Cell Biol	168(2)	303-313	2005	IF
51-9000	Rb anti-Claudin-1	Mertens AEE, et al.	J Cell Biol	170(7)	1029-1037	2005	WB, IF (Ms)
51-9000	Rb anti-Claudin-1	Peitsch WK, et al.	J Invest Dermatol	125	761-774	2005	IF
51-9000	Rb anti-Claudin-1	Weng X-H, et al.	Am J Physiol Gastroint Live r Physiol	288	G705-717	2005	IF (dog intestine, 1:1,000)
51-9000	Rb anti-Claudin-1	Yu ASL, et al.	Am J Physiol Cell Physiol	288	C1231-1241	2005	WB
51-9000	Rb anti-Claudin-1	Eugenin EA, et al.	J Neurosci	26(4)	1098-1106	2006	Confocal IF (1:800)
51-9000	Rb anti-Claudin-1	Musch MW, et al.	Am J Physiol Gastrointest Li ver Physiol	290	G222-231	2006	Confocal IF (Caco-2), WB
51-9000	Rb anti-Claudin-1	Vermeer PD, et al.	J Biol Chem	281(3)	1725-1730	2006	IP (1:500), WB (1:500), ICC (1:100)
61-7300	Rb anti-ZO-1	Antonetti DA, et al.	J Biol Chem	274(33)	23463-23467	1999	IP
61-7300	Rb anti-ZO-1	Mann B, et al.	PNAS	96	1603-1608	1999	WB
61-7300	Rb anti-ZO-1	Quinlan MP, Hyatt JL.	Cell Growth Differ	10(12)	839-854	1999	IF
61-7300	Rb anti-ZO-1	Woo PL, et al.	J Biol Chem	274(46)	32818-32828	1999	IF, ICC
61-7300	Rb anti-ZO-1	Bazzoni G, et al.	J Biol Chem	275(27)	20520-20526	2000	WB, IHC
61-7300	Rb anti-ZO-1	Chen Y-H, et al.	Mol Biol Cell	11	849-862	2000	IP, WB
61-7300	Rb anti-ZO-1	Dickman KG, et al.	Am J Physiol Gastrointestin al Liver Physiol	279	757-766	2000	IF
61-7300	Rb anti-ZO-1	Hellstrom M, et al.	J Cell Biol	153(3)	543-553	2000	IHC (Ms brain)
61-7300	Rb anti-ZO-1	Kevil CG, et al.	Am J Physiol Cell Physiol	279	C21-30	2000	IF (1:250), WB
61-7300	Rb anti-ZO-1	Li D, Mrsny RJ.	J Cell Biol	148(4)	791-800	2000	WB, IF
61-7300	Rb anti-ZO-1	Liang TW, et al.	Am J Physiol Cell Physiol	279	1733-1743	2000	IF
61-7300	Rb anti-ZO-1	Mattagajasingh SN, et al.	J Biol Chem	275(39)	30573-30585	2000	WB, IP, IF
61-7300	Rb anti-ZO-1	Ng KH, et al.	J Cell Sci	113	4241-4251	2000	IF
61-7300	Rb anti-ZO-1	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
61-7300	Rb anti-ZO-1	Ryeom SM, et al.	Mol Biol of Cell	11	1687-1696	2000	IF
61-7300	Rb anti-ZO-1	Singh U, et al.	J Biol Chem	275(24)	18407-18417	2000	IF
61-7300	Rb anti-ZO-1	Troxell ML, et al.	J Cell Sci	113	985-996	2000	WB IF
61-7300	Rb anti-ZO-1	Yañez-Mo M, et al	J Cell Sci	114	577-587	2000	IF
61-7300	Rb anti-ZO-1	Chen MC, et al.	Am J Physiol Gastrointestin al Liver Physiol	280	264-272	2001	IF
61-7300	Rb anti-ZO-1	Cohen CJ, et al.	PNAS	98(26)	15191-15196	2001	IF
61-7300	Rb anti-ZO-1	Davidson G, et al.	J Cell Sci	114	3359-3366	2001	IF
61-7300	Rb anti-ZO-1	Hirata, K et al	J Biol Chem	276(19)	16223-16231	2001	IF
61-7300	Rb anti-ZO-1	Huber JD, et al.	Am J Physiol Heart Circ Phy siol	280	1241-1248	2001	WB
61-7300	Rb anti-ZO-1	Janssens B, et al.	J Cell Sci	114	3177-3188	2001	IF
61-7300	Rb anti-ZO-1	Laing, J.G. et al	J Biol Chem	276(25)	23051-23055	2001	IF
61-7300	Rb anti-ZO-1	Lund RD, et al.	PNAS	98(17)	9942-9947	2001	ICC
61-7300	Rb anti-ZO-1	Martinez-Estradam O, et al.	J Biol Chem	276(12)	9291-9296	2001	IF
61-7300	Rb anti-ZO-1	Mauro L, et al.	J Biol Chem	276(43)	39892-39897	2001	WB, IP
61-7300	Rb anti-ZO-1	Naishiro Y, et al.	Cancer Res	61	2751-2758	2001	IF
61-7300	Rb anti-ZO-1	Nishiyama R, et al.	J Biol Chem	276(38)	35571-35580	2001	IHC, Blot Hybridization
61-7300	Rb anti-ZO-1	Palmer HG, et al.	J Cell Biol	154(2)	369-387	2001	IF
61-7300	Rb anti-ZO-1	Simons M, et al.	Am J Pathol	159(3)	1069-1077	2001	WB
61-7300	Rb anti-ZO-1	Straight SW, et al.	Mol Biol Cell	12	1329-1340	2001	IF
61-7300	Rb anti-ZO-1	van der Goes A, et al.	FASEB J	15(10)	1852-1854	2001	IHC
61-7300	Rb anti-ZO-1	Wang W, et al.	Am J Physiol Heart Circ Phy siol	280	434-440	2001	WB IF
61-7300	Rb anti-ZO-1	Yeaman C, et al.	J Cell Biol	155(4)	593-604	2001	IF
61-7300	Rb anti-ZO-1	Cooper CD, Lampe PD.	J Biol Chem	277(47)	44962-44968	2002	WB
61-7300	Rb anti-ZO-1	Gelebart P, et al.	J Biol Chem	277(29)	26310-26320	2002	ICC
61-7300	Rb anti-ZO-1	Glynne PA, et al.	J Biol Chem	277(36)	33132-33138	2002	IF
61-7300	Rb anti-ZO-1	Govindarajan R, et al.	J Biol Chem	277(51)	50087-50097	2002
61-7300	Rb anti-ZO-1	Gritli-Linde A, et al.	Development	129	5323-5337	2002	IHC (Ms, PFA, paraffin)
61-7300	Rb anti-ZO-1	Hamazaki Y, et al.	J Biol Chem	277(1)	455-461	2002	IF
61-7300	Rb anti-ZO-1	Janda E, et al.	J Cell Biol	156(2)	299-313	2002	ICC (froz)
61-7300	Rb anti-ZO-1	Lavelle J, et al.	Am J Physiol Renal Physiol	283	F242-253	2002	IF (Rt)
61-7300	Rb anti-ZO-1	Li Q, et al.	J Biol Chem	277(48)	46447-46455	2002	IHC, WB
61-7300	Rb anti-ZO-1	Nasdala I, et al.	J Biol Chem	277(18)	16294-16303	2002	IF, Confocal microscopy, Immunogold labeling
61-7300	Rb anti-ZO-1	Nielsen PA, et al.	J Biol Chem	277(41)	38272-38283	2002	IF, WB
61-7300	Rb anti-ZO-1	Nishimura M, et al.	J Biol Chem	277(7)	5583-5587	2002	IF, ICC
61-7300	Rb anti-ZO-1	Oliver JA, et al.	Am J Physiol Renal Physiol	283	F799-809	2002	IF
61-7300	Rb anti-ZO-1	Oneyama C, et al.	Oncogene	21	2037-2050	2002
61-7300	Rb anti-ZO-1	Pedram A, et al.	J Biol Chem	277(46)	44385-44398	2002	IF
61-7300	Rb anti-ZO-1	Poliak S, et al.	J Cell Biol	159(2)	361-371	2002	IF
61-7300	Rb anti-ZO-1	Ramalingam TS, et al.	EMBO J	21	590-601	2002	IF
61-7300	Rb anti-ZO-1	Roh MH, et al.	J Cell Biol	157(1)	161-172	2002	ICC (1:500), IHC (froz rat)
61-7300	Rb anti-ZO-1	Sahai E, Marshall CJ.	Nature Cell Biol	4	408-415	2002
61-7300	Rb anti-ZO-1	Vecsey-Semjen B, et al.	Oncogene	21	4646-4662	2002
61-7300	Rb anti-ZO-1	Ward PD, et al.	J Biol Chem	277(38)	35760-35765	2002	IP
61-7300	Rb anti-ZO-1	You Y, et al.	Am J Physiol Lung Cell Mol Physiol	283	L1315-1321	2002	IF (Ms)
61-7300	Rb anti-ZO-1	Anders M, et al.	Cancer Res	63	2088-2095	2003	WB, IF
61-7300	Rb anti-ZO-1	Basuroy S, et al.	J Biol Chem	278(14)	11916-11924	2003	WB, IF, IP
61-7300	Rb anti-ZO-1	Brown RC, et al.	J Cell Sci	116	693-700	2003	WB (Bv brain, 1:2000)
61-7300	Rb anti-ZO-1	Bruewer M, et al.	J Immunol	171	6164-6172	2003	WB, IF
61-7300	Rb anti-ZO-1	Chin AC, et al.	PNAS	100(19)	11104-11109	2003	IF
61-7300	Rb anti-ZO-1	Coyne CB, et al.	J Pharmacol Exp Ther	305(2)	440-450	2003	IF (1:1000)
61-7300	Rb anti-ZO-1	DeBellefeuille S, et al.	Endocrinology	144(11)	5040-5049	2003	ICC (Rt), WB (Rt)
61-7300	Rb anti-ZO-1	Ebnet K, et al.	J Cell Sci	116	3879-3891	2003	WB, IF
61-7300	Rb anti-ZO-1	Gookin JL, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G967-979	2003	IF (Pig, froz, 1:250)
61-7300	Rb anti-ZO-1	Gu X, et al.	Invest Ophthalmol Vis Sci	44(7)	3219-3225	2003	ICC (Hu, 1:100)
61-7300	Rb anti-ZO-1	Guo X, et al.	Am J Physiol Cell Physiol	285	C1174-1187	2003	WB (Rt), IF (Rt)
61-7300	Rb anti-ZO-1	Hirabayashi S, et al.	Mol Cell Biol	23	4267-4282	2003	IF (Rt)
61-7300	Rb anti-ZO-1	Hopkins AM, et al.	J Cell Sci	116	725-742	2003	WB, IF
61-7300	Rb anti-ZO-1	Kinnemann SC.	EMBO J	22(16)	4143-4154	2003	IF (Rt)
61-7300	Rb anti-ZO-1	Ko J, et al.	J Neurosci	23(5)	1667-1677	2003	WB (2ug/mL)
61-7300	Rb anti-ZO-1	Liu G, et al.	J Clin Invest	112(2)	209-221	2003	WB
61-7300	Rb anti-ZO-1	McDermott JR, et al.	PNAS	100(13)	7761-7766	2003	IHC (froz, Ms)
61-7300	Rb anti-ZO-1	Mehalow AK, et al.	Hum Mol Genet	12(17)	2179-2189	2003	IHC (4% PFA, paraffin); 1:200
61-7300	Rb anti-ZO-1	Nielsen PA, et al.	Mol Biol Cell	14	2470-2481	2003	IHC (Ms eye, PFA-fixed)
61-7300	Rb anti-ZO-1	Ostedgaard LS, et al.	PNAS	100(4)	1937-1942	2003	ICC
61-7300	Rb anti-ZO-1	Peng S, et al.	Invest Ophthalmol Vis Sci	44(2)	808-817	2003	IF (Ck embryo, 1:200)
61-7300	Rb anti-ZO-1	Shingai T, et al.	J Biol Chem	278(37)	35421-35427	2003	IF
61-7300	Rb anti-ZO-1	Tugizov SM, et al.	Nature Medicine	9(3)	307-314	2003	IF
61-7300	Rb anti-ZO-1	Van Itallie CM, et al.	Am J Physiol Renal Physiol	285	F1078-1084	2003	WB
61-7300	Rb anti-ZO-1	Wadham C, et al.	Mol Biol Cell	14(6)	2520-2529	2003	IF (MDCK)
61-7300	Rb anti-ZO-1	Walters RW, et al.	Cell	110	789-799	2003	ICC
61-7300	Rb anti-ZO-1	Wang S-X, et al.	J Biol Chem	278(4)	2713-2722	2003	ICC, IF
61-7300	Rb anti-ZO-1	Yang R, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G621-629	2003	IP
61-7300	Rb anti-ZO-1	Acharya P, et al.	Am J Physiol Renal Physiol	287	F305-318	2004	IF
61-7300	Rb anti-ZO-1	Alvarado JA, et al.	Am J Physiol Cell Physiol	286	C621-663	2004	IHC (Hu cornea, froz, 1:200)
61-7300	Rb anti-ZO-1	Bailey TA, et al.	Invest Ophthalmol Vis Sci	45	675-684	2004	IF
61-7300	Rb anti-ZO-1	Bojarski C, et al.	J Cell Sci	117	2097-2107	2004	IF (Dog), WB (Hu)
61-7300	Rb anti-ZO-1	Brown KA, et al.	Breast Cancer Res	6	R215-231	2004	IF
61-7300	Rb anti-ZO-1	Chavakis T, et al.	J Biol Chem	279(53)	55602-55608	2004	IF (Hu, 5ug/mL)
61-7300	Rb anti-ZO-1	Economou CG, et al.	J Cell Sci	117	3281-3294	2004	Confocal microscopy (HGEC)
61-7300	Rb anti-ZO-1	Gao L, Macara IG.	J Biol Chem	279(40)	41557-41562	2004	IF (1:500)
61-7300	Rb anti-ZO-1	Han X, et al.	Am J Physiol Gastroint Live r Physiol	286	126-136	2004	IP, IF (Ms, froz)
61-7300	Rb anti-ZO-1	Han X, et al.	Am J Physiol Lung Cell Mol Physiol	286	L259-267	2004	IP, IF (Ms, froz)
61-7300	Rb anti-ZO-1	Ikari A, et al.	J Biol Chem	279(52)	54826-54832	2004	IF (MDCK)
61-7300	Rb anti-ZO-1	Ivanov AI, et al.	Mol Cell Biol	15(1)	176-188	2004	IF (Hu)
61-7300	Rb anti-ZO-1	Ivanov AI, et al.	Mol Cell Biol	15(6)	2639-2651	2004	IF (Hu)
61-7300	Rb anti-ZO-1	Kausalya PJ, et al.	Mol Cell Biol	15(12)	5503-5515	2004	IP, IF (Dog)
61-7300	Rb anti-ZO-1	Lee DBN, et al.	Am J Physiol Renal Physiol	287	F481-491	2004
61-7300	Rb anti-ZO-1	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	WB (Ms, Hu)
61-7300	Rb anti-ZO-1	Maass K, et al.	Mol Cell Biol	15(10)	4597-4608	2004	IF (Ms, froz)
61-7300	Rb anti-ZO-1	Ogawa T, et al.	J Cell Sci	117	2087-2096	2004	WB (Rt, 1:2,000)
61-7300	Rb anti-ZO-1	Oliver JA, et al.	J Clin Invest	114(6)	795-804	2004	IF (Rt kidney)
61-7300	Rb anti-ZO-1	Otte J-M, et al.	Am J Physiol Gastroint Live r Physiol	286	613-626	2004
61-7300	Rb anti-ZO-1	Parkinson SJ, et al.	EMBO J	23	77-88	2004	IF
61-7300	Rb anti-ZO-1	Reiser J, et al.	J Clin Invest	113(10)	1390-1397	2004	IF (Ms)
61-7300	Rb anti-ZO-1	Roselli S, et al.	Mol Cell Biol	24(2)	550-560	2004	IF (Ms, froz)
61-7300	Rb anti-ZO-1	Sajjan U, et al.	Infect Immun	72	4188-4199	2004
61-7300	Rb anti-ZO-1	Seth A, et al.	Am J Physiol Gastroint Live r Physiol	287	G510-517	2004
61-7300	Rb anti-ZO-1	Singh AB, Harris RC.	J Biol Chem	279(5)	3543-3552	2004	WB
61-7300	Rb anti-ZO-1	Somasiri A, et al.	Cancer Res	64(15)	5068-5073	2004	ICC (1:200)
61-7300	Rb anti-ZO-1	Wang X, et al.	J Cell Sci	117	53-62	2004	IHC (Ms, froz)
61-7300	Rb anti-ZO-1	Yeaman C, et al.	J Cell Sci	117	559-570	2004	IF (Dog, PFA-fixed, 1:300), IP
61-7300	Rb anti-ZO-1	Bagnoli F, et al.	PNAS	102(45)	16339-16344	2005	IF
61-7300	Rb anti-ZO-1	Chung E, et al.	J Invest Dermatol	124	1134-1140	2005	WB
61-7300	Rb anti-ZO-1	Cross WR, et al.	Am J Physiol Renal Physiol	289	F459-468	2005	Confocal
61-7300	Rb anti-ZO-1	Guo X, et al.	Am J Physiol Gastroint Live r Physiol	288	G1159-1169	2005	WB, IF
61-7300	Rb anti-ZO-1	Jacob C, et al.	J Biol Chem	280(36)	31936-31948	2005	WB, IF (T84 cells)
61-7300	Rb anti-ZO-1	Koike C, et al.	J Neurosci	25(44)	10290-10298	2005	IHC (Ms eye, frozen)
61-7300	Rb anti-ZO-1	Mertens AEE, et al.	J Cell Biol	170(7)	1029-1037	2005	WB, IF (Ms)
61-7300	Rb anti-ZO-1	Peitsch WK, et al.	J Invest Dermatol	125	761-774	2005	IF
61-7300	Rb anti-ZO-1	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	IF, WB
61-7300	Rb anti-ZO-1	Qi A-D, et al.	J Biol Chem	280(32)	29169-29175	2005	Confocal microscopy
61-7300	Rb anti-ZO-1	Quitsch A, et al.	J Neurosci	25(2)	479-487	2005	ICC (MDCKII, 1:750)
61-7300	Rb anti-ZO-1	Shifflett DE, et al.	Lab Invest	85	1308-1324	2005	IHC (Ms, froz, 0.5ug/mL), WB
61-7300	Rb anti-ZO-1	Singh D, et al.	J Biol Chem	280(34)	30416-30421	2005	IP, WB, IF
61-7300	Rb anti-ZO-1	Swiatecka-Urban A, et al.	J Biol Chem	280(44)	36762-36772	2005	ICC
61-7300	Rb anti-ZO-1	Vieira OV, et al.	J Cell Biol	170(4)	521-526	2005	IF
61-7300	Rb anti-ZO-1	Wang Y, et al.	Am J Physiol Renal Physiol	289	F850-862	2005	IF (pig LLC-PK1 cells)
61-7300	Rb anti-ZO-1	Wei C-J, et al.	J Biol Chem	280(20)	19925-19936	2005	ICC
61-7300	Rb anti-ZO-1	Wolff SC, et al.	Am J Physiol Cell Physiol	288	C624-632	2005	Confocal IF
61-7300	Rb anti-ZO-1	Xu H, et al.	Invest Ophthalmol Vis Sci	46	2487-2494	2005	confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000)
61-7300	Rb anti-ZO-1	Yoshii T, et al.	Am J Physiol Gastroint Live r Physiol	288	G564-570	2005	WB
61-7300	Rb anti-ZO-1	Eugenin EA, et al.	J Neurosci	26(4)	1098-1106	2006	Confocal IF (1:800)
71-1400	Rb anti-ZO-2	Mattagajasingh SN, et al.	J Biol Chem	275(39)	30573-30585	2000	WB, IP, IF
71-1400	Rb anti-ZO-2	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
71-1400	Rb anti-ZO-2	Ryeom SM, et al.	Mol Biol of Cell	11	1687-1696	2000	IF
71-1400	Rb anti-ZO-2	Meyer TN, et al.	J Biol Chem	276(25)	22048-22055	2001	WB
71-1400	Rb anti-ZO-2	Nishiyama R, et al.	J Biol Chem	276(38)	35571-35580	2001	IHC, Blot Hybridization
71-1400	Rb anti-ZO-2	Palmer HG, et al.	J Cell Biol	154(2)	369-387	2001	IF
71-1400	Rb anti-ZO-2	Yeaman C, et al.	J Cell Biol	155(4)	593-604	2001	IF
71-1400	Rb anti-ZO-2	Chen ML, et al.	J Biol Chem	277(6)	4247-4254	2002
71-1400	Rb anti-ZO-2	Ward PD, et al.	J Biol Chem	277(38)	35760-35765	2002	IP
71-1400	Rb anti-ZO-2	Guo X, et al.	Am J Physiol Cell Physiol	285	C1174-1187	2003	WB (Rt), IF (Rt)
71-1400	Rb anti-ZO-2	Rafiee P, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G1277-1292	2003	IF (Hu)
71-1400	Rb anti-ZO-2	Traweger A, et al.	J Biol Chem	278(4)	2692-2700	2003	WB, IP, IF
71-1400	Rb anti-ZO-2	Yoo J, et al.	Am J Physiol Cell Physiol	285	C300-309	2003
71-1400	Rb anti-ZO-2	Bojarski C, et al.	J Cell Sci	117	2097-2107	2004	WB (Hu)
71-1400	Rb anti-ZO-2	Kausalya PJ, et al.	Mol Cell Biol	15(12)	5503-5515	2004	IF (Dog)
71-1400	Rb anti-ZO-2	Yeaman C, et al.	J Cell Sci	117	559-570	2004	IP, WB
71-1400	Rb anti-ZO-2	Peitsch WK, et al.	J Invest Dermatol	125	761-774	2005	IF
71-1400	Rb anti-ZO-2	Singh D, et al.	J Biol Chem	280(34)	30416-30421	2005	IP, WB, IF
71-1400	Rb anti-ZO-2	Yu ASL, et al.	Am J Physiol Cell Physiol	288	C1231-1241	2005	WB
71-1400	Rb anti-ZO-2	Guo X, et al.	Am J Physiol Gastroint Live r Physiol	Feb 2005; 10.1152/ajpgi.00407.2004
71-1500	Rb anti-Occludin	Antonetti DA, et al.	J Biol Chem	274(33)	23463-23467	1999	WB
71-1500	Rb anti-Occludin	Lawlor P, et al.	J Neurosci	19(21)	9445-9458	1999	ICC
71-1500	Rb anti-Occludin	Strazielle N, Ghersi-Egea J-F.	J Neurosci	19(15)	6275-6289	1999	ICC
71-1500	Rb anti-Occludin	Tsukamoto T, et al.	J Biol Chem	274(35)	24579-24584	1999	WB, ICC
71-1500	Rb anti-Occludin	Wittchen ES, et al.	J Biol Chem	274(49)	35179-35185	1999	IF
71-1500	Rb anti-Occludin	Bazzoni, G et al	J Biol Chem	275(27)	20520-20526	2000	WB, IHC
71-1500	Rb anti-Occludin	Charron AJ, et al.	J Cell Biol	149(1)	111-124	2000	IF
71-1500	Rb anti-Occludin	Chen Y-H, et al.	Mol Biol Cell	11	849-862	2000	IP, WB, IF
71-1500	Rb anti-Occludin	Clarke H, et al.	J Cell Sci	113	3187-3196	2000	WB
71-1500	Rb anti-Occludin	Dickman KG, et al.	Am J Physiol Gastrointestin al Liver Physiol	279	757-766	2000	IF
71-1500	Rb anti-Occludin	Hellstrom M, et al.	J Cell Biol	153(3)	543-553	2000	IHC (Ms brain)
71-1500	Rb anti-Occludin	Kevil CG, et al.	Am J Physiol Cell Physiol	279	C21-30	2000	IP (1:1000)
71-1500	Rb anti-Occludin	Li D, Mrsny RJ.	J Bell Biol	148(4)	791-800	2000	WB, IF
71-1500	Rb anti-Occludin	Liang TW, et al.	Am J Physiol Cell Physiol	279	1733-1743	2000	IF
71-1500	Rb anti-Occludin	Mattagajasingh SN, et al.	J Biol Chem	275(39)	30573-30585	2000	WB, IP, IF
71-1500	Rb anti-Occludin	McCarthy KM, et al.	J Cell Sci	113	3387-3398	2000	WB IF
71-1500	Rb anti-Occludin	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
71-1500	Rb anti-Occludin	Ryeom SM, et al.	Mol Biol of Cell	11	1687-1696	2000	IF
71-1500	Rb anti-Occludin	Troxell ML, et al.	J Cell Sci	113	985-996	2000	WB IF
71-1500	Rb anti-Occludin	Andreeva AY, et al.	J Biol Chem	276(42)	38480-38486	2001	IP, IF
71-1500	Rb anti-Occludin	Hirase T, et al.	J Biol Chem	276(13)	10423-10431	2001	IP
71-1500	Rb anti-Occludin	Huber JD, et al.	Am J Physiol Heart Circ Phy siol	280	1241-1248	2001	WB
71-1500	Rb anti-Occludin	Kucharzik T, et al.	Am J Pathol	159(6)	2001-2009	2001	IF, WB
71-1500	Rb anti-Occludin	Meyer TN, et al	J Biol Chem	276(25)	22048-22055	2001	WB
71-1500	Rb anti-Occludin	Nishiyama R, et al.	J Biol Chem	276(38)	35571-35580	2001	IHC, Blot Hybridization
71-1500	Rb anti-Occludin	Palmer HG, et al.	J Cell Biol	154(2)	369-387	2001	IF
71-1500	Rb anti-Occludin	Singh U, et al.	J Biol Chem	276(36)	33402-33412	2001	WB
71-1500	Rb anti-Occludin	Wang W, et al.	Am J Physiol Heart Circ Phy siol	280	434-440	2001	WB IF
71-1500	Rb anti-Occludin	Wojciak-Stothard B, et al.	J Cell Sci	114	1343-1355	2001	IF
71-1500	Rb anti-Occludin	Yeaman C, et al.	J Cell Biol	155(4)	593-604	2001	IF
71-1500	Rb anti-Occludin	Burgel N, et al.	Gastroenterology	123	433-443	2002	WB
71-1500	Rb anti-Occludin	Chen ML, et al.	J Biol Chem	277(6)	4247-4254	2002	IF, WB
71-1500	Rb anti-Occludin	Edens HA, et al.	J Immunol	169	476-486	2002	IF, WB
71-1500	Rb anti-Occludin	Feltri ML, et al.	J Cell Biol	156(1)	199-209	2002	IHC (Ms, PFA-fixed, froz)
71-1500	Rb anti-Occludin	Forster C, et al.	PNAS	99(24)	15578-15583	2002	IHC (frozen, Ms)
71-1500	Rb anti-Occludin	Nasdala I, et al.	J Biol Chem	277(18)	16294-16303	2002	Confocal microscopy, Immunogold labeling
71-1500	Rb anti-Occludin	Nishimura M, et al.	J Biol Chem	277(7)	5583-5587	2002	IF
71-1500	Rb anti-Occludin	Nunbhakdi-Craig V, et al.	J Cell Biol	158(5)	967-978	2002	WB, IP, IF
71-1500	Rb anti-Occludin	Traweger A, et al.	J Biol Chem	277(12)	10201-10208	2002	IF WB
71-1500	Rb anti-Occludin	Wang Y, et al.	Am J Obstet Gynecol	186	214-220	2002	IF
71-1500	Rb anti-Occludin	Ward PD, et al.	J Biol Chem	277(38)	35760-35765	2002	WB
71-1500	Rb anti-Occludin	Barber AJ, Antonetti DA.	Invest Ophthalmol Vis Sci	44	5410-5416	2003	IHC (Rt retina, PFA-fixed)
71-1500	Rb anti-Occludin	Basuroy S, et al.	J Biol Chem	278(14)	11916-11924	2003	IF
71-1500	Rb anti-Occludin	Brown RC, et al.	J Cell Sci	116	693-700	2003	WB (Bv brain, 1:2000)
71-1500	Rb anti-Occludin	Bruewer M, et al.	J Immunol	171	6164-6172	2003	WB, IF
71-1500	Rb anti-Occludin	Hopkins AM, et al.	J Cell Sci	116	725-742	2003	WB, IF
71-1500	Rb anti-Occludin	Leung LW, et al.	Am J Physiol Cell Physiol	284	C1021-1030	2003	WB
71-1500	Rb anti-Occludin	McDermott JR, et al.	PNAS	100(13)	7761-7766	2003	WB
71-1500	Rb anti-Occludin	Meyer TN, et al.	Am J Physiol Cell Physiol	285	C1281-1293	2003	IP, WB
71-1500	Rb anti-Occludin	Mizuno K, et al.	J Biol Chem	278(33)	31240-31250	2003	IF
71-1500	Rb anti-Occludin	Nunbhakdi-Craig V, et al.	J Virol	77(5)	2807-2818	2003	IF, WB, Confocal
71-1500	Rb anti-Occludin	Peng B-H, et al.	J Biol Chem	278(49)	49644-49651	2003	WB, IP
71-1500	Rb anti-Occludin	Rajasekaran SA, et al.	Am J Physiol Cell Physiol	284	C1497-1507	2003	IP
71-1500	Rb anti-Occludin	Reuss B, et al.	J Neurosci	23(16)	6404-6412	2003	IF (Ms), WB (Ms)
71-1500	Rb anti-Occludin	Rukstalis JM, et al.	J Cell Sci	116	3315-3325	2003	IHC (Ms, 1:100)
71-1500	Rb anti-Occludin	Tafazoli F, et al.	Infect Immun	71(2)	872-881	2003	IF
71-1500	Rb anti-Occludin	Takekuni K, et al.	J Biol Chem	278(8)	5497-5500	2003	IF
71-1500	Rb anti-Occludin	Tian Y-C, et al.	Am J Physiol Renal Physiol	285	F130-142	2003	ICC (1:100)
71-1500	Rb anti-Occludin	Traweger A, et al.	J Biol Chem	278(4)	2692-2700	2003	IF
71-1500	Rb anti-Occludin	Tugizov SM, et al.	Nature Medicine	9(3)	307-314	2003	IF
71-1500	Rb anti-Occludin	Van Itallie CM, et al.	Am J Physiol Renal Physiol	285	F1078-1084	2003	WB
71-1500	Rb anti-Occludin	Wolburg H, et al.	Acta Neuropathol	105	586-592	2003	IF (mouse)
71-1500	Rb anti-Occludin	Yang R, et al.	Am J Physiol Gastrointest Li ver Physiol	285	G621-629	2003	IP
71-1500	Rb anti-Occludin	Acharya P, et al.	Am J Physiol Renal Physiol	287	F305-318	2004	IF
71-1500	Rb anti-Occludin	Bailey TA, et al.	Invest Ophthalmol Vis Sci	45	675-684	2004	IF
71-1500	Rb anti-Occludin	Barmeyer C, et al.	Am J Physiol Gastrointest Li ver Physiol	286	G244-252	2004	WB (Ms)
71-1500	Rb anti-Occludin	Bojarski C, et al.	J Cell Sci	117	2097-2107	2004	IF (Dog), WB
71-1500	Rb anti-Occludin	Broughman JR, et al.	Am J Physiol Cell Physiol	287	C1312-1323	2004
71-1500	Rb anti-Occludin	Epple HJ, et al.	Infect Immun	72	4848-4858	2004
71-1500	Rb anti-Occludin	Gao L, Macara IG.	J Biol Chem	279(40)	41557-41562	2004	IF (1:500)
71-1500	Rb anti-Occludin	Han X, et al.	Am J Physiol Gastroint Live r Physiol	286	126-136	2004	IP, IF (Ms, froz)
71-1500	Rb anti-Occludin	Han X, et al.	Am J Physiol Lung Cell Mol Physiol	286	L259-267	2004	IP, IF (Ms, froz)
71-1500	Rb anti-Occludin	Ivanov AI, et al.	Mol Cell Biol	15(1)	176-188	2004	IF (Hu), WB
71-1500	Rb anti-Occludin	Ivanov AI, et al.	Mol Cell Biol	15(6)	2639-2651	2004	IF (Hu)
71-1500	Rb anti-Occludin	Lee DBN, et al.	Am J Physiol Renal Physiol	287	F481-491	2004
71-1500	Rb anti-Occludin	Luton F, et al.	Mol Cell Biol	15(3)	1134-1145	2004	WB
71-1500	Rb anti-Occludin	Ogawa T, et al.	J Cell Sci	117	2087-2096	2004	WB (Rt, 1:2,000)
71-1500	Rb anti-Occludin	Seth A, et al.	Am J Physiol Gastroint Live r Physiol	287	G510-517	2004
71-1500	Rb anti-Occludin	Singh AB, Harris RC.	J Biol Chem	279(5)	3543-3552	2004	WB
71-1500	Rb anti-Occludin	Wang X, et al.	J Cell Sci	117	53-62	2004	IHC (Ms, froz)
71-1500	Rb anti-Occludin	Yeaman C, et al.	J Cell Sci	117	559-570	2004	IP, WB
71-1500	Rb anti-Occludin	Brooks TA, et al.	Am J Physiol Heart Circ Phy siol	289	H738-743	2005
71-1500	Rb anti-Occludin	Chung E, et al.	J Invest Dermatol	124	1134-1140	2005	WB
71-1500	Rb anti-Occludin	Cross WR, et al.	Am J Physiol Renal Physiol	289	F459-468	2005	Confocal
71-1500	Rb anti-Occludin	Guo X, et al.	Am J Physiol Gastroint Live r Physiol	288	G1159-1169	2005	WB, IF
71-1500	Rb anti-Occludin	Lipschutz J, et al.	J Biol Chem	280	3780-3788	2005	WB (1:1000), IF (MDCK, 1:250)
71-1500	Rb anti-Occludin	Meng J, et al.	PNAS	102(46)	16696-16700	2005	IF (Ms testis, paraffin)
71-1500	Rb anti-Occludin	Mertens AEE, et al.	J Cell Biol	170(7)	1029-1037	2005	WB, IF (Ms)
71-1500	Rb anti-Occludin	Peitsch WK, et al.	J Invest Dermatol	125	761-774	2005	IF
71-1500	Rb anti-Occludin	Xu H, et al.	Invest Ophthalmol Vis Sci	46	2487-2494	2005	confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000)
71-1500	Rb anti-Occludin	Yu ASL, et al.	Am J Physiol Cell Physiol	288	C1231-1241	2005	WB
71-1500	Rb anti-Occludin	Dokladny K, et al.	Am J Physiol Gastrointest Li ver Physiol	290	G204-212	2006	WB, IF (Caco-2)
71-1500	Rb anti-Occludin	Eugenin EA, et al.	J Neurosci	26(4)	1098-1106	2006	Confocal IF (1:800)
71-1500	Rb anti-Occludin	Vermeer PD, et al.	J Biol Chem	281(3)	1725-1730	2006	WB (1:500), ICC (1:100)
71-1500	Rb anti-Occludin	Sakakibara A, et al.	J Cell Biol	137(6)	1393-1401	1997	IP
71-1500	Rb anti-Occludin	Van Itallie CM, et al	J Cell Sci	110	1113-1121	1997	WB (1:1000)
71-1500	Rb anti-Occludin	Fanning AS, et al.	J Biol Chem	275(45)	29745-29753	1998	IF
71-1500	Rb anti-Occludin	Jou TS, et al.	J Cell Biology	142(1)	101-115	1998	IF, WB
71-1500	Rb anti-Occludin	Martin-Padura I, et al.	J Cell Biol	142(1)	117-127	1998	IF
71-1500	Rb anti-Occludin	Wu S, et al.	PNAS	95	14979-14848	1998	WB
71-7800	Rb anti-Claudin-1/-3 (MH25)	Chen Y-H, et al.	Mol Biol Cell	11	849-862	2000	IP, WB, IF
71-7800	Rb anti-Claudin-1/-3 (MH25)	Hellstrom M, et al.	J Cell Biol	153(3)	543-553	2000	IHC (Ms brain)
71-7800	Rb anti-Claudin-1/-3 (MH25)	Li D, Mrsny RJ.	J Cell Biol	148(4)	791-800	2000	WB, IF
71-7800	Rb anti-Claudin-1/-3 (MH25)	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
71-7800	Rb anti-Claudin-1/-3 (MH25)	Van Itallie C, et al.	J Clin Invest	107	1319-1327	2001	WB
71-7800	Rb anti-Claudin-1/-3 (MH25)	Edens HA, et al.	J Immunol	169	476-486	2002	IF, WB
71-7800	Rb anti-Claudin-1/-3 (MH25)	Folpe AL, et al.	Am J Surg Pathol	26(12)	1620-26	2002	IHC (FFPE)
71-7800	Rb anti-Claudin-1/-3 (MH25)	Furuse M, et al.	J Cell Biol	156(6)	1099-1111	2002	IF (Ms liver, froz), WB
71-7800	Rb anti-Claudin-1/-3 (MH25)	Gudjonsson T, et al.	Genes Dev	16(6)	693-706	2002	ICC
71-7800	Rb anti-Claudin-1/-3 (MH25)	Kiuchi-Saishin M, et al.	J Am Soc Nephrol	13	875-886	2002	IF (Ms kidney, froz)
71-7800	Rb anti-Claudin-1/-3 (MH25)	Nishimura M, et al.	J Biol Chem	277(7)	5583-5587	2002	IF
71-7800	Rb anti-Claudin-1/-3 (MH25)	Nunbhakdi-Craig V, et al.	J Cell Biol	158(5)	967-978	2002	IP, WB, IF
71-7800	Rb anti-Claudin-1/-3 (MH25)	Sakaguchi T, et al.	J Biol Chem	277(24)	21361-21370	2002	IF
71-7800	Rb anti-Claudin-1/-3 (MH25)	Turksen K, Troy T-C.	Development	129	1775-1784	2002	IHC (Ms, paraffin, 1:100)
71-7800	Rb anti-Claudin-1/-3 (MH25)	Brown RC, et al.	J Cell Sci	116	693-700	2003	WB (Bv brain, 1:1000)
71-7800	Rb anti-Claudin-1/-3 (MH25)	Bruewer M, et al.	J Immunol	171	6164-6172	2003	WB, IF
71-7800	Rb anti-Claudin-1/-3 (MH25)	Fukuhara A, et al.	J Biol Chem	278(51)	51885-51893	2003	ICC
71-7800	Rb anti-Claudin-1/-3 (MH25)	Nunbhakdi-Craig V, et al.	J Virol	77(5)	2807-2818	2003	IF, WB, Confocal
71-7800	Rb anti-Claudin-1/-3 (MH25)	Wolburg H, et al.	Acta Neuropathol	105	586-592	2003	IF, WB (mouse)
71-7800	Rb anti-Claudin-1/-3 (MH25)	Young P, et al.	EMBO J	22	5723-5733	2003	IHC (Ms, PFA_fixed, paraffin)
71-7800	Rb anti-Claudin-1/-3 (MH25)	Xu H, et al.	Invest Ophthalmol Vis Sci	46	2487-2494	2005	confocal IF (Ms retina, wholemount, 1:100), WB (1:3,000)

Cat #	Product	Authors	Journal	Volume	Page(s)	Year	Application(s)
Adherens Junction Antibody Product References
13-1700	Ms anti-E-cadherin (HECD-1)	Hoover KB, et al.	Am J Pathol	153(6)	1767-1773	1998	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Auersperg N, et al.	PNAS	96	6249-6254	1999	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Day ML, et al.	J Biol Chem	274(14)	9656-9664	1999	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Corn PG, et al.	Clin Cancer Res	6	4243-4248	2000	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Gottardi CJ, et al.	J Cell Biol	153(5)	1049-1059	2000	WB, IF
13-1700	Ms anti-E-cadherin (HECD-1)	Hazan RB, et al.	J Cell Biol	148(4)	779-790	2000	WB, IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Heimann R, et al.	Cancer Res	60	298-304	2000	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Hsu M, et al.	J Cell Sci	113	1535-1542	2000	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Acs G, et al.	Arch Pathol Lab Med	125	198-201	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Adam L, et al.	J Biol Chem	276(30)	28443-28450	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Gallicano GI, et al.	Development	128	929-941	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Gregoire L, et al.	Clin Cancer Res	7	4280-4287	2001	WB, IHC (paraffin)
13-1700	Ms anti-E-cadherin (HECD-1)	Jacobs TW, et al.	Am J Surg Pathol	25(2)	229-36	2001	IHC(FFPE)1:500
13-1700	Ms anti-E-cadherin (HECD-1)	Kaplan DK, et al.	J Biol Chem	276(47)	44037-44043	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Luo Y, et al.	Development	128	459-469	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Machado JC, et al.	Oncogene	20	1525-1528	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Meigs TE, et al	PNAS	98(2)	519-534	2001	IF, WB
13-1700	Ms anti-E-cadherin (HECD-1)	Naora H, et al.	PNAS	98(26)	15209-15214	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Rashid MG, et al.	Cancer Res	61	489-492	2001	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Vallorosi CJ, et al.	J Biol Chem	275(5)	3328-3334	2001	IP and WB
13-1700	Ms anti-E-cadherin (HECD-1)	Zavadil J, et al.	PNAS	98(12)	6686-6691	2001	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Zhong Y, et al.	Clin Cancer Res	7	1683-1687	2001	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Alpaugh ML, et al.	Oncogene	21	3631-3643	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Edens HA, et al.	J Immunol	169	476-486	2002	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Govindarajan R, et al.	J Biol Chem	277(51)	50087-50097	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Hajra KM, et al.	Cancer Res	62	1613-1618	2002	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Kim J-T, et al.	J Biol Chem	277(35)	31938-31948	2002	IF, adhesion blocking studies
13-1700	Ms anti-E-cadherin (HECD-1)	Laura RP, et al.	J Biol Chem	277(15)	12906-12914	2002	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Li Q, et al.	J Biol Chem	277(48)	46447-46455	2002	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Muller N, et al.	Oncogene	21	6049-6058	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Niessen CM, Gumbiner BM.	J Cell Biol	156(2)	389-399	2002	?
13-1700	Ms anti-E-cadherin (HECD-1)	Sahai E, Marshall CJ.	Nature Cell Biol	4	408-415	2002
13-1700	Ms anti-E-cadherin (HECD-1)	Tran NL, et al.	J Biol Chem	277(36)	32905-32914	2002	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Weaver VM, et al.	Cancer Cell	2	205-216	2002	blocking
13-1700	Ms anti-E-cadherin (HECD-1)	Boussioutas A, et al.	Cancer Res	63	2569-2577	2003	IHC (paraffin)
13-1700	Ms anti-E-cadherin (HECD-1)	Chan AOO, et al.	J Clin Oncol	21(12)	2288-2293	2003	IHC (paraffin, 1:200)
13-1700	Ms anti-E-cadherin (HECD-1)	Kowalski PJ, et al.	Breast Cancer Res	5	R217-R222	2003	IHC (FFPE, Ventana Biotek Techmate 500)
13-1700	Ms anti-E-cadherin (HECD-1)	Kuefer R, et al.	Clin Cancer Res	9(17)	6447-6452	2003	WB (Hu prostate)
13-1700	Ms anti-E-cadherin (HECD-1)	Rios-Doria J, et al.	J Biol Chem	278(2)	1372-1379	2003	WB
13-1700	Ms anti-E-cadherin (HECD-1)	Suriano G, et al.	Hum Mol Genet	12	575-582	2003	IHC (froz)
13-1700	Ms anti-E-cadherin (HECD-1)	Tian F, et al.	Cancer Res	63	8284-8292	2003	IF, WB
13-1700	Ms anti-E-cadherin (HECD-1)	Troyanovsky RB, et al.	Mol Cell Biol	23(22)	7965-7972	2003	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Gottardi CJ, Gumbiner BM.	Am J Physiol Cell Physiol	286	C747-756	2004	WB (1:10,000)
13-1700	Ms anti-E-cadherin (HECD-1)	Haven CJ, et al.	Cancer Res	64(20)	7405-7411	2004	IHC (paraffin, 1:500)
13-1700	Ms anti-E-cadherin (HECD-1)	Ivanov AI, et al.	Mol Cell Biol	15(6)	2639-2651	2004	IF (Hu)
13-1700	Ms anti-E-cadherin (HECD-1)	Lecuit M, et al.	PNAS	101(16)	6152-6157	2004	IHC (FFPE and froz, 1:500)
13-1700	Ms anti-E-cadherin (HECD-1)	Tobey NA, et al.	Am J Physiol Gastrointest Li ver Physiol	286	G1042-1049	2004	IHC (Rb, PFA-fixed, paraffin)
13-1700	Ms anti-E-cadherin (HECD-1)	Peignon G, et al.	J Biol Chem	281(6)	3560-3568	2006	IF (1:200)
13-1700	Ms anti-E-cadherin (HECD-1)	Horiguchi Y, et al.	J Histochem Cytochem	42(10)	1333-1340	1994	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Watabe M, et al.	J Cell Biol	127(1)	247-256	1994	IP
13-1700	Ms anti-E-cadherin (HECD-1)	Blauvelt A, et al.	J Invest Dermatology	104	193-6	1995	Flow Cytometry
13-1700	Ms anti-E-cadherin (HECD-1)	Glukhova M, et al.	Am J Pathol	146	706-716	1995	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Sanna M, et al.	Anat Pathol	105(4)	394-402	1995	IHC (frozen)
13-1700	Ms anti-E-cadherin (HECD-1)	Siitonen SM, et al.	Anatomic Pathology	105(4)	394-402	1996	IHC (1:800)
13-1700	Ms anti-E-cadherin (HECD-1)	Braga VMM, et al.	J Cell Biol	137(6)	1421-1431	1997	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Hoover KB, et al.	Am J Pathol	153(6)	1767-1773	1998	IF
13-1700	Ms anti-E-cadherin (HECD-1)	Kondo K, et al.	Cancer Res	58	2014-2019	1998
13-1700	Ms anti-E-cadherin (HECD-1)	Soto H, et al.	Human Pathology	30(11)	1344-1349	1999
13-1700	Ms anti-E-cadherin (HECD-1)	Acs G, et al.	Arch Pathol Lab Med	125	198-201	2001	IHC
13-1700	Ms anti-E-cadherin (HECD-1)	Vallorosi CJ, et al.	J Biol Chem	275(5)	3328-3334	2001	IP and WB
13-1700	Ms anti-E-cadherin (HECD-1)	Zavadil, et al.	PNAS	98(12)	7573-7578	2001	IF and WB
13-1800	Rt anti-E-cadherin (ECCD-1)	Tinkle CL, et al.	PNAS	101(2)	552-557	2004	WB, IF
13-1800	Rt anti-E-cadherin (ECCD-1)	Takeichi M.	Development	102	639-655	1988	WB
13-1800	Rt anti-E-cadherin (ECCD-1)	Hirai Y, et al.	Development	105	271-277	1989	Cell-cell adhesion blocking (pos), IHC
13-1800	Rt anti-E-cadherin (ECCD-1)	Nose A, et al.	Cell	61	147-155	1990	Epitope Mapping
13-1800	Rt anti-E-cadherin (ECCD-1)	Tang A, et al.	Nature	361	82-85	1993	Binding comp,
13-1800	Rt anti-E-cadherin (ECCD-1)	Babich M, et al.	Life Sciences	54(11)	PL-201-PL20 8	1994	Immunostain
13-1800	Rt anti-E-cadherin (ECCD-1)	Fannon A, et al.	J Cell Biol	129 (1)	189-202	1995
13-1800	Rt anti-E-cadherin (ECCD-1)	Roh J-Y, et al.	J Cell Biol	128(5)	939-947	1995	Cell-cell adhesion blocking (pos)
13-1900	Rt anti-E-cadherin (ECCD-2)	Hosono S, et al.	J Biol Chem	275(15)	10943-10953	2000	WB
13-1900	Rt anti-E-cadherin (ECCD-2)	Mulac-Jericevic B, et al.	Science	289	1751-1754	2000	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Carothers AM, et al.	J Biol Chem	276(42)	39094-39102	2001	WB, IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Bouchard M, et al.	Genes Dev	16(22)	2958-2970	2002	IHC (Ms)
13-1900	Rt anti-E-cadherin (ECCD-2)	DasGupta R, et al.	J Cell Biol	158(2)	331-344	2002	IF (Ms), WB
13-1900	Rt anti-E-cadherin (ECCD-2)	Gritli-Linde A, et al.	Development	129	5323-5337	2002	IHC (Ms, PFA, paraffin)
13-1900	Rt anti-E-cadherin (ECCD-2)	Lopez T, Hanahan D.	Cancer Cell	1	339-353	2002	IHC - frozen, Ms
13-1900	Rt anti-E-cadherin (ECCD-2)	Ngan ESW, et al.	PNAS	99(17)	11187-11192	2002	IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Pelengaris S, et al.	Cell	109	321-334	2002	IHC - paraffin, Ms
13-1900	Rt anti-E-cadherin (ECCD-2)	Wali RK, et al.	Cancer Epidemiol Biomarker s Prev	11	1653-1662	2002	WB, IHC (rat)
13-1900	Rt anti-E-cadherin (ECCD-2)	Welm BE, et al.	J Cell Biol	157(4)	703-714	2002	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Yoon M, Spear PG.	J Virol	76(14)	7203-7208	2002	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Davis J, et al.	J Cell Sci	116	2157-2167	2003	WB, IHC (Ms eye, froz, 0.1ug/mL)
13-1900	Rt anti-E-cadherin (ECCD-2)	Gouyon F, et al.	J Physiol	552	823-832	2003
13-1900	Rt anti-E-cadherin (ECCD-2)	Kopp T, et al.	J Immunol	171	5438-5444	2003	FC
13-1900	Rt anti-E-cadherin (ECCD-2)	Lallemand D, et al.	Genes Dev	17(9)	1090-1100	2003	IF (Ms, 1:250)
13-1900	Rt anti-E-cadherin (ECCD-2)	Sakai T, et al.	Genes Dev	17(7)	926-940	2003	ICC (Ms)
13-1900	Rt anti-E-cadherin (ECCD-2)	Devaux JJ, et al.	J Neurosci	24(5)	1236-1244	2004	IHC (Ms, Rt, froz, 1:50)
13-1900	Rt anti-E-cadherin (ECCD-2)	Fouquet S, et al.	J Biol Chem	279(41)	43061-43069	2004	IF (Ms intestine, 1:250), WB (1:2,500)
13-1900	Rt anti-E-cadherin (ECCD-2)	Hogan C, et al.	Mol Cell Biol	24(15)	6690-6700	2004	IF (Hu)
13-1900	Rt anti-E-cadherin (ECCD-2)	Linehan MM, et al.	J Virol	78	2530-2536	2004	IF (Ms, froz)
13-1900	Rt anti-E-cadherin (ECCD-2)	Oshima RG, et al.	Cancer Res	64	169-179	2004	IF (Ms tissue, froz)
13-1900	Rt anti-E-cadherin (ECCD-2)	Wandzioch E, et al.	PNAS	101(47)	16549-16554	2004	IHC (Ms embryo, paraffin)
13-1900	Rt anti-E-cadherin (ECCD-2)	Tricaud N, et al.	J Neurosci	25(13)	3259-3269	2005	IHC (Ms sciatic nerve, froz)
13-1900	Rt anti-E-cadherin (ECCD-2)	Peignon G, et al.	J Biol Chem	281(6)	3560-3568	2006	IF (1:250)
13-1900	Rt anti-E-cadherin (ECCD-2)	Takeichi M.	Development	102	639-655	1988	IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Hirai Y, et al.	Development	105	271-277	1989	Cell-cell adhesion blocking (neg ctrl)
13-1900	Rt anti-E-cadherin (ECCD-2)	Hirano S, et al.	Cell	70	293-301	1992	WB, IP
13-1900	Rt anti-E-cadherin (ECCD-2)	Tang A, et al.	Nature	361	82-85	1993	Flow
13-1900	Rt anti-E-cadherin (ECCD-2)	Babich M and Foti RP.	Life Sciences	54(11)	PL-201-PL20 8	1994	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Horiguchi Y, et al.	J Histochem Cytochem	42(10)	1333-1340	1994	IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Nagafuchi A, et al.	J Cell Biol	127(1)	235-245	1994	IB,IHC
13-1900	Rt anti-E-cadherin (ECCD-2)	Tsarfaty I, et al.	Science	263	98-101	1994	IHC (paraffin)
13-1900	Rt anti-E-cadherin (ECCD-2)	Watabe M, et al.	J Cell Biol	127(1)	247-251	1994
13-1900	Rt anti-E-cadherin (ECCD-2)	Fannon AM, et al.	J Cell Biol	129(1)	189-202	1995	IP, WB, IHC (frozen)
13-1900	Rt anti-E-cadherin (ECCD-2)	Palacios J, et al.	Am J Pathol	146	605-612	1995	IHC(oct)
13-1900	Rt anti-E-cadherin (ECCD-2)	Roh J-Y, et al.	J Cell Biol	128(5)	939-947	1995	IP, IF, WB, Flow
13-1900	Rt anti-E-cadherin (ECCD-2)	Shibamoto S, et al.	J Cell Biol	128(5)	949-957	1995	HECD-2-IP, WB
13-1900	Rt anti-E-cadherin (ECCD-2)	Mbalaviele G, et al.	Cancer Res	56	4063-4070	1996	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Braga VMM, et al.	J Cell Biol	137(6)	1421-1431	1997
13-1900	Rt anti-E-cadherin (ECCD-2)	Dunn RJ, et al.	J Histochem Cytochem	45(1)	129-141	1997	IHC (frozen/OCT)
13-1900	Rt anti-E-cadherin (ECCD-2)	Gallicano GI, et al.	J Cell Biol	143(7)	2009-2022	1998	IF
13-1900	Rt anti-E-cadherin (ECCD-2)	Perl AK, et al.	Nature Med	5(3)	286-291	1999	F
13-2000	Rt anti-P-cadherin	Liu G, et al.	J Clin Invest	112(2)	209-221	2003	Injected into rats
13-2000	Rt anti-P-cadherin	Tinkle CL, et al.	PNAS	101(2)	552-557	2004	WB, IF
13-2000	Rt anti-P-cadherin	Rico M, et al.	Am J Physiol Renal Physiol	289	F431-441	2005	IF (1:50)
13-2000	Rt anti-P-cadherin	Takeichi, M.	Development	102	639-655	1988	Adhesion Inhibition
13-2000	Rt anti-P-cadherin	Hirai Y, et al.	Development	105	271-277	1989	Cell-cell adhesion blocking (pos), IHC
13-2000	Rt anti-P-cadherin	Nose A, et al.	Cell	61	147-155	1990	Epitope Mapping
13-2000	Rt anti-P-cadherin	Tang A, et al.	Nature	361	82-85	1993	Inhibition studies,
13-2000	Rt anti-P-cadherin	Roh J-Y, et al.	J Cell Biol	128(5)	939-947	1995	Cell-cell adhesion blocking (neg. cntl.)
13-2000	Rt anti-P-cadherin	Jamora C, et al.	Nature	422	317-322	2003	IHC
13-2100	Rt anti-N-cadherin (NCD-2)	Mahlapuu M, et al.	Development	128	155-166	2001	IHC
13-2100	Rt anti-N-cadherin (NCD-2)	Ryan PL, et al	PNAS	98(8)	4323-4327	2001	ICC
13-2100	Rt anti-N-cadherin (NCD-2)	Robinson EE, et al.	J Cell Sci	116	377-386	2003	FC
13-2100	Rt anti-N-cadherin (NCD-2)	Ciesiolka M, et al.	J Cell Sci	117	4325-4339	2004	WB (Xen)
13-2100	Rt anti-N-cadherin (NCD-2)	Hatta K, et al.	Nature	320(6061)	447-449	1986	WB, IHC (frozen)
13-2100	Rt anti-N-cadherin (NCD-2)	Takeichi M.	Development	102	639-655	1988	Adhesion Inhibition
13-2100	Rt anti-N-cadherin (NCD-2)	Nose A, et al.	Cell	61	147-155	1990	Epitope Mapping
13-2100	Rt anti-N-cadherin (NCD-2)	Hirano S, et al.	Cell	70	293-301	1992	WB, IP, IF
13-2100	Rt anti-N-cadherin (NCD-2)	Bixby JL, et al.	J Neurosci	13(8)	3421-3432	1993	WB
13-2100	Rt anti-N-cadherin (NCD-2)	Balsamo J, et al.	J Cell Biol	129(5)	1391-1401	1995	Affinity Chromatography, WB
13-2100	Rt anti-N-cadherin (NCD-2)	Zong CS, et al.	J Biol Chem	272(3)	1500-1506	1997	WB ( no data shown )
13-2100	Rt anti-N-cadherin (NCD-2)	Huttenlocher A, et al.	J Cell Biol	141(2)	515-526	1998	cell inhibition
13-5700	Ms anti-E-cadherin (SHE78-7)	Day ML, et al.	J Biol Chem	274(14)	9656-9664	1999	blocking studies
13-5700	Ms anti-E-cadherin (SHE78-7)	Mueller S, et al.	Cancer Res	60	156-163	2000	blocking studies
13-5700	Ms anti-E-cadherin (SHE78-7)	Reinacher-Schick A, Gumbiner BM.	J Cell Biol	152(3)	491-502	2001	WB
13-5700	Ms anti-E-cadherin (SHE78-7)	Klingelhofer J, et al.	Oncogene	22	1181-1188	2003
13-5700	Ms anti-E-cadherin (SHE78-7)	Mariner DJ, et al.	J Cell Sci	117	1339-1350	2004	Blocking (1ug/mL)
13-5700	Ms anti-E-cadherin (SHE78-7)	Merot Y, et al.	J Biol Chem	279(25)	26184-26191	2004	WB (1:1000)
13-5700	Ms anti-E-cadherin (SHE78-7)	Dalrymple S, et al.	Cancer Res	65	9269-9279	2005	Blocking (2ug/mL)
13-5700	Ms anti-E-cadherin (SHE78-7)	Pang J-H, et al.	J Biol Chem	280(4)	3043-3050	2005	IP
13-5700	Ms anti-E-cadherin (SHE78-7)	Katayama M, et al.	J Oncol Int	5	1049-1057	1994	ELISA, WB, Adhesion Inhibition
13-5700	Ms anti-E-cadherin (SHE78-7)	Watabe M, et al.	J Cell Biol	127(1)	247-256	1994	IP
13-5700	Ms anti-E-cadherin (SHE78-7)	Mitra, et al.	Lab Invest	76	99-107	1997	Blocking
13-5700	Ms anti-E-cadherin (SHE78-7)	St. Croix B, et al.	J Cell Biol	142(2)	557-571	1998	Inhibition
13-5700	Ms anti-E-cadherin (SHE78-7)	Orford K, et al.	J Cell Biol	146(4)	855-867	1999
13-5800	Ms anti-P-cadherin	Muller N, et al.	Oncogene	21	6049-6058	2002
13-5800	Ms anti-P-cadherin	Shimoyama Y, et al.	J Cell Biol	109	1787-1794	1989	ICC, WB, cell-cell adhesion blocking (pos)
13-5800	Ms anti-P-cadherin	Shimoyama Y, et al.	Cancer Res	49	2128-2133	1989	WB, IHC (frozen)
13-5800	Ms anti-P-cadherin	Shimoyama Y, et al.	Cancer Res	51	2185-2192	1991	WB, IHC
13-5800	Ms anti-P-cadherin	Doki Y, et al.	Cancer Res	53	3421-3426	1993	WB
13-5800	Ms anti-P-cadherin	Morton RA, et al.	Cancer Res	53	3585-3590	1993	IF, WB, IP
13-5800	Ms anti-P-cadherin	Rasbridge SA.	J Pathol	169	245-250	1993	IHC (frozen)
13-5800	Ms anti-P-cadherin	Yasui W, et al.	Internation J of Cancer	54	49-52	1993	WB, IHC (frozen)
13-5800	Ms anti-P-cadherin	Hodivala KJ.	J Cell Biol	124(4)	589-600	1994	IF, Stratification Inhibition
13-5800	Ms anti-P-cadherin	Glukhova M, et al.	Am J Pathol	146	706-716	1995	IF
13-5800	Ms anti-P-cadherin	Palacios J, et al.	Am J Pathol	146	605-612	1995	IHC(oct)
13-5800	Ms anti-P-cadherin	Braga VMM, et al.	J Cell Biol	137 (6)	1421-1431	1997
13-8400	Ms anti-beta-Catenin	Sakanaka C, Williams LT.	J Biol Chem	274(20)	14090-14093	1999	IP
13-8400	Ms anti-beta-Catenin	Woo PL, et al.	J Biol Chem	274(46)	32818-32828	1999	ICC
13-8400	Ms anti-beta-Catenin	Tachibana K, et al.	J Cell Biol	150(5)	1161-1175	2000	IF
13-8400	Ms anti-beta-Catenin	Adam L, et al.	J Biol Chem	276(30)	28443-28450	2001	IP, IF
13-8400	Ms anti-beta-Catenin	Dottori M, et al	Development	128	4127-4138	2001	IHC
13-8400	Ms anti-beta-Catenin	Kaplan DK, et al.	J Biol Chem	276(47)	44037-44043	2001	WB, IF
13-8400	Ms anti-beta-Catenin	Meigs TE, et al.	PNAS	98(2)	519-534	2001	WB, IF
13-8400	Ms anti-beta-Catenin	Rashid MG, et al.	Cancer Res	61	489-492	2001	IP, WB
13-8400	Ms anti-beta-Catenin	Vallorosi CJ, et al.	J Biol Chem	275(2)	3328-3334	2001	IP and WB
13-8400	Ms anti-beta-Catenin	Carmichael J, et al.	J Biol Chem	277(37)	33791-33798	2002	WB, ICC
13-8400	Ms anti-beta-Catenin	Kramer KL, et al.	Cell	111	981-990	2002	WB
13-8400	Ms anti-beta-Catenin	Ren J, et al.	J Biol Chem	277(20)	17616-17622	2002	WB
13-8400	Ms anti-beta-Catenin	Swinney DC, et al.	J Biol Chem	277(26)	23573-23581	2002	ELISA
13-8400	Ms anti-beta-Catenin	Warchol ME.	J Neurosci	22(7)	2607-2616	2002	ICC (Ck)
13-8400	Ms anti-beta-Catenin	Bamji SX, et al.	Neuron	40	719-731	2003	IF (rats)
13-8400	Ms anti-beta-Catenin	Luo Y, Radice GL.	J Cell Sci	116	1471-1479	2003	ICC (Ms, PFA-fixed, 1:100)
13-8400	Ms anti-beta-Catenin	Matsumura K, et al.	Blood	101	1367-1374	2003
13-8400	Ms anti-beta-Catenin	Rios-Doria J, et al.	J Biol Chem	278(2)	1372-1379	2003	IP
13-8400	Ms anti-beta-Catenin	Hill DA, et al.	J Cell Sci	117	5847-5854	2004	WB
13-8400	Ms anti-beta-Catenin	Kaplan DD, et al.	J Biol Chem	279(12)	10829-10832	2004	IF
13-8400	Ms anti-beta-Catenin	Li WY, et al.	Am J Physiol Renal Physiol	286	F1063-1071	2004	IF (Ms kidney, froz, 1:100)
13-8400	Ms anti-beta-Catenin	Ogawa T, et al.	J Cell Sci	117	2087-2096	2004	WB (Rt, 1:2,000)
13-8400	Ms anti-beta-Catenin	Yamamoto M.	J Biol Chem	272(19)	12492-12494	1997	IP, WB
13-8400	Ms anti-beta-Catenin	Sakanaka C, et al.	PNAS	95	3020-3023	1998	IP
13-8400	Ms anti-beta-Catenin	Wu S, et al.	PNAS	95	14979-14984	1998	WB
13-8400	Ms anti-beta-Catenin	Meigs TE, et al.	PNAS	98(2)	519-534	2001	WB, IF
13-8400	Ms anti-beta-Catenin	Vallorosi CJ, et al.	J Biol Chem	275(5)	3328-3334	2001	IP and WB
13-8500	Ms anti-gamma-Catenin	Ilan N, et al.	J Biol Chem	275(28)	21435-21443	2000	IHC
13-8500	Ms anti-gamma-Catenin	Grooteclaes M, et al.	PNAS	100(8)	4568-4573	2003	WB
13-8500	Ms anti-gamma-Catenin	Klingelhofer J, et al.	Oncogene	22	1181-1188	2003
13-8500	Ms anti-gamma-Catenin	Li Y, et al.	Molec Cancer Res	1	765-775	2003	WB, IF
13-8500	Ms anti-gamma-Catenin	Kaplan DD, et al.	J Biol Chem	279(12)	10829-10832	2004	WB
13-8500	Ms anti-gamma-Catenin	Descargues P, et al.	Nature Genetics	37	56-65	2005	WB, IHC (ms)
13-8500	Ms anti-gamma-Catenin	Silberberg M, et al.	Am J Physiol Renal Physiol	288	F1153-1163	2005	Confocal IF (Hu kidney, 1:100)
13-9700	Ms anti-alpha-Catenin	Allport JR, et al.	J Cell Biol	148(1)	203-216	1999	IF
13-9700	Ms anti-alpha-Catenin	Giannini AL, et al.	J Biol Chem	275(29)	21883-21888	2000	WB
13-9700	Ms anti-alpha-Catenin	Carothers AM, et al.	J Biol Chem	276(42)	39094-39102	2001	WB
13-9700	Ms anti-alpha-Catenin	Scheffers MS, et al.	Hum Mol Genet	11	59-67	2002
13-9700	Ms anti-alpha-Catenin	Jacquemier J, et al.	Cancer Res	65(3)	767-779	2005	IHC (FFPE)
13-9700	Ms anti-alpha-Catenin	Allport JR, et al.	J Exp Med	186	517-527	1997	IF
13-9700	Ms anti-alpha-Catenin	Yamamoto M.	J Biol Chem	272(19)	12492-12494	1997	IP, WB
32-6100	Ms anti-Desmoglein-2	Silberberg M, et al.	Am J Physiol Renal Physiol	288	F1153-1163	2005	IF (Hu kidney cells, 1:25)
33-3900	Ms anti-N-cadherin	Hazan RB, et al.	J Cell Biol	148(4)	779-790	2000	WB, IHC, migration inhibition
33-3900	Ms anti-N-cadherin	van Raamsdock CD, et al.	Development	127	5439-5448	2000	IHC
33-3900	Ms anti-N-cadherin	Gottardi CJ, et al.	J Cell Biol	153(5)	1049-1059	2001	WB
33-3900	Ms anti-N-cadherin	Janssens B, et al.	J Cell Sci	114	3177-3188	2001	IF
33-3900	Ms anti-N-cadherin	Kotelevets L, et al.	J Cell Biol	155(7)	1129-1135	2001	WB
33-3900	Ms anti-N-cadherin	Luo Y, et al.	Development	128	459-469	2001	IHC
33-3900	Ms anti-N-cadherin	Xu X, et al.	J Cell Biol	154(1)	217-229	2001	IHC
33-3900	Ms anti-N-cadherin (3B9)	Andrieux A, et al.	Genes Dev	16(18)	2350-2364	2002	WB (Ms)
33-3900	Ms anti-N-cadherin	Laura RP, et al.	J Biol Chem	277(15)	12906-12914	2002	WB
33-3900	Ms anti-N-cadherin	Niessen CM, Gumbiner BM.	J Cell Biol	156(2)	389-399	2002	IF
33-3900	Ms anti-N-cadherin	Suyama K, et al.	Cancer Cell	2	301-314	2002	WB, IP
33-3900	Ms anti-N-cadherin (3B9)	Davani S, et al.	Circulation	108	253-258	2003	IHC (Rt heart, paraffin,
33-3900	Ms anti-N-cadherin	Kang J-S, et al.	PNAS	100(7)	3989-3994	2003	WB
33-3900	Ms anti-N-cadherin	Krueger SR, et al.	Neuron	40	945-957	2003	IF (rats)
33-3900	Ms anti-N-cadherin (3B9)	Luo Y, Radice GL.	J Cell Sci	116	1471-1479	2003	ICC (Ms, PFA-fixed, 1:100)
33-3900	Ms anti-N-cadherin (3B9)	Robinson EE, et al.	J Cell Sci	116	377-386	2003	WB
33-3900	Ms anti-N-cadherin (3B9)	Rubinek T, et al.	J Clin Endocrinol Metab	88(8)	3724-3730	2003	IF (paraffin, 1:100)
33-3900	Ms anti-N-cadherin (3B9)	Bharti S, et al.	Mol Cell Biol	15(1)	397-406	2004	WB
33-3900	Ms anti-N-cadherin (3B9)	Hill DA, et al.	J Cell Sci	117	5847-5854	2004	WB
33-3900	Ms anti-N-cadherin (3B9)	Luo Y, Radice GL.	J Cell Biol	169(1)	29-34	2005	IF (HUVEC, HVMEC), Confirmation of siRNA knockdown (IF)
33-3900	Ms anti-N-cadherin (3B9)	Pon YL, et al.	J Biol Chem	280(15)	15438-15448	2005	IP, WB (1:1,000)
33-3900	Ms anti-N-cadherin (3B9)	Siu MKY, et al.	J Biol Chem	280(26)	25029-25047	2005	IP
33-3900	Ms anti-N-cadherin (3B9)	Wattel S, et al.	Oncogene	24	6902-6916	2005	WB, IHC (Hu thyroid adenoma, froz)
33-3900	Ms anti-N-cadherin (3B9)	Wei C-J, et al.	J Biol Chem	280(20)	19925-19936	2005	WB, ICC
33-4000	Ms anti-E-cadherin (4A2C7)	Kim M-K, et al.	App Immunohistochem Mole c Morphol	10(4)	332-338	2002	IHC (paraffin)
33-4000	Ms anti-E-cadherin (4A2C7)	Luo Y, Radice GL.	J Cell Sci	116	1471-1479	2003	ICC (Ms, PFA-fixed, 1:100)
33-4000	Ms anti-E-cadherin (4A2C7)	Palacios J, et al.	Clin Cancer Res	9(10)	3606-3614	2003	IHC (Hu breast cancer, paraffin, 1:200)
33-4000	Ms anti-E-cadherin (4A2C7)	Guerini V, et al.	Cancer Res	65(12)	5445-5453	2005	WB (1:200)
33-9600	Ms anti-p120 Catenin (C-term)	Wu J, et al.	Hybridoma	17(2)	175-183	1999	WB, IP, IF
33-9600	Ms anti-p120 Catenin (C-term)	Humtsoe JO, et al.	EMBO J	22	1539-1554	2003	WB
33-9600	Ms anti-p120 Catenin	Tinkle CL, et al.	PNAS	101(2)	552-557	2004	WB, IF
33-9700	Ms anti-p120 Catenin (N-term)	Wu J, et al.	Hybridoma	17(2)	175-183	1999	WB, IP, IF
33-9700	Ms anti-p120 Catenin (N-term)	Wadham C, et al.	Mol Biol Cell	14(6)	2520-2529	2003	WB
35-4700	Ms anti-Ksp-cadherin	Thedieck C, et al.	Br J Cancer	92	2010-2017	2005	ICC (Hu RCC cells, 1:50), IHC (Hu kidney, froz, 1:50)
35-4700	Ms anti-Ksp-cadherin	Yamamoto M, et al.	Am J Physiol Renal Physiol	290	F52-60	2006	IHC (Ms froz, 1:100), confocal IF
71-1200	Rb anti-alpha-Catenin	Quinlan MP, Hyatt JL.	Cell Growth Differ	10	839-854	1999	IP, IF
71-1200	Rb anti-alpha-Catenin	Mauro L, et al.	J Biol Chem	276(43)	39892-39897	2001	WB, IP
71-1200	Rb anti-alpha-Catenin	Meyer TN, et al.	Am J Physiol Cell Physiol	285	C1281-1293	2003	IP, WB
71-1200	Rb anti-alpha-Catenin	Mucha DR, et al.	Am J Physiol Heart Circ Phy siol	284	H994-1002	2003	ICC (Bv, 1:100)
71-1200	Rb anti-alpha-Catenin	Hinz B, et al.	Mol Cell Biol	15(9)	4310-4320	2004	WB (Rt)
71-1200	Rb anti-alpha-Catenin	Osta WA, et al.	Cancer Res	64(16)	5818-5824	2004	WB
71-1200	Rb anti-alpha-Catenin	Kolly C, et al.	J Invest Dermatol	124	1014-1025	2005	WB (Dog)
71-1200	Rb anti-alpha-Catenin	Margulis A, et al.	Cancer Res	65(5)	1783-1791	2005	WB
71-1200	Rb anti-alpha-Catenin	St Croix B, et al.	J Cell Biology	142(2)	557-571	1998	WB
71-2700	Rb anti-beta-Catenin	Coyne CB, et al.	J Pharmacol Exp Ther	305(2)	440-450	2003	IF (1:1000)
71-2700	Rb anti-beta-Catenin	Meyer TN, et al.	Am J Physiol Cell Physiol	285	C1281-1293	2003	IP, WB
71-2700	Rb anti-beta-Catenin	Walters RW, et al.	Cell	110	789-799	2003	WB, IP, ICC
71-2700	Rb anti-beta-Catenin	Hinz B, et al.	Mol Cell Biol	15(9)	4310-4320	2004	IF (Rt, froz), WB (Rt)
71-2700	Rb anti-beta-Catenin	Osta WA, et al.	Cancer Res	64(16)	5818-5824	2004	WB
71-2700	Rb anti-beta-Catenin	Reymond N, et al.	J Exp Med	199	1331-1341	2004	IF (Hu)
71-2700	Rb anti-beta-Catenin	Margulis A, et al.	Cancer Res	65(5)	1783-1791	2005	IF
71-2700	Rb anti-beta-Catenin	Yongqing L, et al.	J Biol Chem	276(38)	35239-35242	2001	WB
71-7100	Rb anti-pan-cadherin	Colonnese MT, et al.	J Neurophysiol	89	57-68	2003	WB (Rt)
71-7100	Rb anti-pan-cadherin	Croft DR, et al.	Cancer Res	64(24)	8994-9001	2004	IF
71-7100	Rb anti-pan-cadherin	Hinz B, et al.	Mol Cell Biol	15(9)	4310-4320	2004	WB (Rt)
71-7100	Rb anti-pan-cadherin	Ren Y-G, et al.	Mol Cell Biol	15(11)	5064-5074	2004	WB (Hu)
71-7100	Rb anti-pan-cadherin	Schedin PJ, et al.	Oncogene	23	1766-1779	2004	IHC (1:400)
71-7600	Rb anti-cadherin-11	Straub BK, et al.	J Cell Sci	116	4985-4995	2003
71-7600	Rb anti-cadherin-11	Morimoto AM, et al.	Oncogene	23	1618-1626	2004
Gap Junction Antibody Product References
13-8100	Ms anti-CX26 (12H10)	Ito A, et al.	J Clin Invest	105(9)	1189-97	2000	WB 1:300, IHC (PFA-fixed, Hu)
13-8100	Ms anti-CX26 (12H10)	Rash JE, et al.	J Neurosci	21	1983-2000	2001
13-8100	Ms anti-CX26 (12H10)	Rouan F, et al.	J Cell Sci	114	2105-2113	2001	IHC (frozen), WB
13-8100	Ms anti-CX26 (12H10)	Solomon IC, et al.	Resp Pathol	129	101-121	2001	IHC
13-8100	Ms anti-CX26 (12H10)	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF WB
13-8100	Ms anti-CX26 (12H10)	Walcott B, et al.	Am J Physiol Cell Physiol	282	C501-507	2002	WB (1:1000)
13-8100	Ms anti-CX26 (12H10)	Aasen T, et al.	Oncogene	22	7969-7980	2003
13-8100	Ms anti-CX26 (12H10)	Gemel J, et al.	J Cell Sci	117	2469-2480	2004	IF (1:500)
13-8100	Ms anti-CX26 (12H10)	Saito T, et al.	Oncogene	23	1109-1116	2004	IF (1:500)
13-8100	Ms anti-CX26 (12H10)	Thomas T, et al.	J Biol Chem	279(18)	19157-19168	2004	ICC (1:200)
13-8100	Ms anti-Cx26 (CX-12H10)	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005	IF
13-8100	Ms anti-CX26 (12H10)	You S, et al.	Cancer Res	58	1498-1502	1998	IHC (Frozen)
13-8200	Ms anti-CX32 (CX-2C2)	Alvarez-Maubecin V, et al.	J Neurosci	20(11)	4091-4098	2000	ICC (rat)
13-8200	Ms anti-CX32 (CX-2C2)	Peracchia C, et al.	J Biol Chem	275(34)	26220-26224	2000	IF
13-8200	Ms anti-CX32 (CX-2C2)	Rash JE, et al.	PNAS	97(13)	7573-7578	2000	WB
13-8200	Ms anti-CX32 (CX-2C2)	Klepeis VE, et al.	J Cell Sci	114	4185-4195	2001	WB
13-8200	Ms anti-CX32 (CX-2C2)	Rash JE, et al.	J Neurosci	21	1983-2000	2001	WB, Immunogold labeling
13-8200	Ms anti-CX32 (CX-2C2)	Solomon IC, et al.	Resp Pathol	129	101-121	2001	IHC
13-8200	Ms anti-CX32 (CX-2C2)	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF WB
13-8200	Ms anti-CX32 (CX-2C2)	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:500), WB
13-8200	Ms anti-CX32 (CX-2C2)	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
13-8200	Ms anti-CX32 (CX-2C2)	Saito T, et al.	Oncogene	23	1109-1116	2004	IF (1:500)
13-8200	Ms anti-Cx32 (CX-2C2)	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005
13-8200	Ms anti-CX32 (CX-2C2)	Li J, et al.	J Comp Neurol	379(4)	571-591	1997	WB (1:200), IHC (froz), EM
13-8300	Ms anti-CX43	Beardslee MA, et al.	Circ Res	87	656-662	2000	WB IF
13-8300	Ms anti-CX43	Ciray HN, et al.	Am J Obstet Gynecol	182	926-930	2000	IF
13-8300	Ms anti-Cx43	Quist AP, et al.	J Cell Biol	148(5)	1063-1074	2000	IF
13-8300	Ms anti-CX43	Bruzzone S, et al.	J Biol Chem	276(51)	48300-48308	2001	WB
13-8300	Ms anti-CX43	Klepeis VE, et al.	J Cell Sci	114	4185-4195	2001	WB
13-8300	Ms anti-Cx43	Di W-L, et al.	Hum Mol Genet	11	2005-2014	2002	IF (froz, 1:100)
13-8300	Ms anti-CX43	Dubina MV, et al.	Oncogene	21	4992-4996	2002
13-8300	Ms anti-CX43	Piechocki MP, et al.	Clin Cancer Res	8	870-877	2002	IP, WB
13-8300	Ms anti-CX43	Caton D, et al.	J Cell Sci	116	2285-2294	2003	WB (Rt)
13-8300	Ms anti-CX43	Chen J-T, et al.	Clin Cancer Res	9(11)	4200-4204	2003	WB (Hu, 1:1000)
13-8300	Ms anti-CX43	Christ GJ, et al.	Am J Physiol Regulatory Int egrative Comp Physiol	284	R1241-1248	2003	WB (1:500)
13-8300	Ms anti-Cx43	Eugenin EA, et al.	J Immunol	170	1320-1328	2003	WB, IF
13-8300	Ms anti-CX43	Gutstein DE, et al.	J Cell Sci	116	875-885	2003	WB, IF (Ms heart, froz)
13-8300	Ms anti-CX43	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	WB
13-8300	Ms anti-Cx43 (CX-1B1)	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005	IF, WB
13-8300	Ms anti-CX43	Li W, et al.	J Biol Chem	280(9)	7941-7948	2005	WB, IF
13-8300	Ms anti-CX43	Muramatsu T.	J Histochem Cytochem	44(1)	49-56	1996
13-8300	Ms anti-CX43	Hayashi T, et al.	Cancer Letters	112	103-111	1997	WB
13-8300	Ms anti-CX43	Koval M, et al.	J Cell Biol	137(4)	847-857	1997	IF
13-8300	Ms anti-CX43	Masgrau-Peya E, et al.	J Histochem Cytochem	45(9)	1207-1215	1997	IF 1:500dilution
13-8300	Ms anti-CX43	Nagy JI, et al.	Exp Cell Res	236	127-136	1997	WB, IHC, EM
13-8300	Ms anti-CX43	Xie H, et al.	J Cell Biol	137(1)	203-210	1997	WB
13-8300	Ms anti-CX43	Li WEI, et al.	Eur J Neurosci	10	2444-2463	1998	WB, IHC
13-8300	Ms anti-CX43	Martin PE, et al.	J Biol Chem	273(3)	1719-1726	1998	WB
13-8300	Ms anti-CX43	Toyofuku T, et al.	J Biol Chem	273(3)	1519-1528	1998	WB
13-8300	Ms anti-CX43	Bittman KS, et al.	Cerebral Cortex	9	188-195	1999	IF
13-8300	Ms anti-CX43	Nagy JI, et al.	Neuroscience	88(2)	447-468	1999	IF
13-8300	Ms anti-CX43	Xie H, et al.	Neuroscience	88(2)	447-468	1999
13-8300	Ms anti-CX43	Li WEI, Nagy JI.	Neurosci	97 (1)	113-123	2000	WB, iHC
13-8300	Ms anti-CX43	Li WEI, Nagy JI.	Eur J Neurosci	12	2644-2650	2000
33-2500	Ms anti-Cx30	Nagy JI, et al.	Neuroscience	88	447-468	1999
33-2500	Ms anti-Cx30	Nagy JI, et al.	J Comp Neurol	441(4)	302-323	2001	IF (1:500)
33-2500	Ms anti-Cx30	Rash JE, et al.	J Neurosci	21	1983-2000	2001	WB, IHC (froz), Immunogold labeling
33-2500	Ms anti-Cx30	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:500), WB
33-2500	Ms anti-Cx30	Sun J, et al.	Am J Physiol Cell Physiol	288	C613-623	2005	WB (1:1,000), IP, IHC (Ms cochlea, 1:200)
33-2500	Ms anti-Cx30	Jagger DJ, Forge A.	J Neurosci	26(4)	1260-1268	2006	IF (Rt cochlea, 1:200)
33-4300	Ms anti-Cx50	Klepeis VE, et al.	J Cell Sci	114	4185-4195	2001	WB
33-4300	Ms anti-Cx50	Lin D, et al.	Mol Vision	10	688-695	2004	WB, IP (Rt)
33-5800	Ms anti-CX26	Nagy JI, et al.	J Comp Neurol	441	302-323	2001	WB, IF
33-5800	Ms anti-CX26	Rouan F, et al.	J Cell Sci	114	2105-2113	2001	IHC (frozen), WB
33-5800	Ms anti-CX26	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
33-5800	Ms anti-Cx26	Di W-L, et al.	Hum Mol Genet	11	2005-2014	2002	IF (froz, 1:100)
33-5800	Ms anti-CX26	Richard G, et al.	Am J Hum Genet	70	1341-1348	2002	IF
33-5800	Ms anti-Cx26	Aasen T, et al.	Oncogene	22	7969-7980	2003	IF (paraffin)
33-5800	Ms anti-Cx26	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:200), WB
34-4200	Rb anti-Cx29	Li X, et al.	Eur J Neurosci	16	795-806	2002	ICC (froz Ms sciatic nerve), immunogold labeling, WB
34-4200	Rb anti-Cx29	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:400), WB
34-4200	Rb anti-Cx29	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
34-4200	Rb anti-Cx29	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
34-4200	Rb anti-Cx29	Tricaud N, et al.	J Neurosci	25(13)	3259-3269	2005	IHC (Ms sciatic nerve, froz)
34-5700	Rb anti-Connexin 32	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:100), WB
34-5700	Rb anti-Connexin 32	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
34-5700	Rb anti-Connexin 32	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
34-5700	Rb anti-Connexin 32	Zhu L, et al.	Mol Cell Biol	24(7)	2673-2681	2004	IHC (Ms, 1:200)
35-5000	Ms anti-Cx43	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:150), WB
35-5000	Ms anti-Cx43	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
35-5000	Ms anti-Cx43	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
35-5000	Ms anti-Cx43	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB, IF
35-8900	Ms anti-Cx32	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:400), WB
35-8900	Ms anti-Cx32	Nagy JI, et al.	J Comp Neurol	464	356-370	2003	IF, WB
35-8900	Ms anti-Cx32	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB, IF
36-4600	Rb anti-Cx36	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	WB (Ms)
36-4600	Rb anti-Cx36	Rash JE, et al.	J Neurocytol	33	131-152	2004	IHC (Ms, froz), Immunogold labeling
36-4600	Rb anti-Cx36	Lin B, et al.	J Neurosci	25(28)	6696-6701	2005	ICC (Ms retina)
36-4700	Rb anti-CX47	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:400), WB
36-4700	Rb anti-CX47	Li X, et al.	Neuroscience	126	611-630	2004	WB (Ms), IHC (Ms, froz)
36-4700	Rb anti-Cx47	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB
37-4500	Ms anti-Cx47	Penes MC, et al.	Eur J Neurosci	22	404-418	2005	WB
37-4600	Ms anti-Cx36	Li X, et al.	Eur J Neurosci	19	2132-2146	2004	IHC (froz, Ms), WB (Ms)
37-4600	Ms anti-Cx36	Rash JE, et al.	J Neurocytol	33	131-152	2004	IHC (Ms, froz)
51-2800	Rb anti-Cx26	Nagy JI, et al.	J Comp Neurol	441	302-323	2001	IF, WB
51-2800	Rb anti-CX26	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
51-2800	Rb anti-CX26	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC, IF
51-2800	Rb anti-Cx26	Nagy JI, et al.	Glia	44	205-218	2003	IF (1:200), WB
51-2800	Rb anti-CX26	Rukstalis JM, et al.	J Cell Sci	116	3315-3325	2003	IHC (Ms, 1:200)
51-2800	Rb anti-Cx26	Teubner B, et al.	Hum Mol Genet	12	13-21	2003	IHC (Ms, froz, 1:100)
51-2800	Rb anti-Cx26	Lahlou H, et al.	Mol Cell Biol	25(10)	4034-4045	2005	IP, IF (Hu Bx-PC-3)
51-6200	Rb anti-Cx36	Rash JE, et al.	J Neurosci	21	1983-2000	2001	Immunogold labeling
51-6200	Rb anti-Cx36	Yi H, Massey SC.	PNAS	102(37)	13313-13318	2005	ICC (Ms retina, 1:250)
51-6200	Rb anti-Cx36	Rash JE, et al.	PNAS	97(13)	7573-7578	2000
51-6300	Rb anti-Cx36	Rash JE, et al.	J Neurosci	21	1983-2000	2001	Immunogold labeling
51-6300	Rb anti-Cx36	Li X, et al.	Eur J Neurosci	19	2132-2146	2003	WB (Ms), IP
51-6300	Rb anti-Cx36	Pereda A, et al.	J Neurosci	23(20)	7489-7503	2003	Immunogold labeling
51-6300	Rb anti-Cx36	Rash JE, et al.	J Neurocytol	33	131-152	2004	IHC (Ms, froz), Immunogold labeling
51-6300	Rb anti-Cx36	Maxeiner S, et al.	J Neurosci	25(3)	566-576	2005	IHC (Ms retina, PFA-fixed, 1:500)
51-6300	Rb anti-Cx36	Rash JE, et al.	PNAS	97(13)	7573-7578	2000	WB
71-0500	Rb anti-Cx26	Ciray HN, et al.	Am J Obstet Gynecol	182	926-930	2000	IF
71-0500	Rb anti-CX26	Guo Y, et al.	Am J Physiol Lung Cell Mol Physiol	280	191-202	2001	WB
71-0500	Rb anti-Cx26	Nagy JI, et al.	J Comp Neurol	441	302-323	2001	WB, IF
71-0500	Rb anti-CX26	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
71-0500	Rb anti-CX26	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF
71-0500	Rb anti-Cx26	Qin H, et al.	J Biol Chem	277(32)	29132-29138	2002	ICC
71-0500	Rb anti-Cx26	Walcott B, et al.	Am J Physiol Cell Physiol	282	C501-507	2002	ICC (Ms)
71-0500	Rb anti-Cx26	Dufresne J, et al.	Am J Physiol Cell Physiol	284	C33-43	2003	ICC (rat)
71-0500	Rb anti-CX26	El-Sabban ME, et al.	J Cell Sci	116	3531-3541	2003	WB, ICC (Ms)
71-0500	Rb anti-Cx26	Locke D, et al.	Biochemistry	44(39)	13027-13042	2005	ICC, WB
71-0500	Rb anti-Cx26	Kelsell DP, et al.	Nature	387	80-83	1997	IHC (frozen, Hu) 1:100
71-0500	Rb anti-Cx26	Nagy JI, et al.	Neuroscience	78(2)	533-548	1997	WB (1:1000), IHC (frozen) 1:500s
71-0500	Rb anti-Cx26	Bittman KS, et al	Cerebral Cortex	9	188-195	1999	IF
71-0500	Rb anti-Cx26	Nagy JI, et al.	Neuroscience	88(2)	447-468	1999	WB
71-0500	Rb anti-Cx26	Nursat A, et al.	J Biol Chem	275(38)	29816-29822	2000	WB
71-0500	Rb anti-Cx26	Yazulla S, Studholme KM.	J Neurocytology	30	551-592	2001	ICC (Zebrafish 1:100)
71-0600	Rb anti-CX32	Das Sarma J, et al.	J Cell Sci	114	4013-4024	2001	IF
71-0600	Rb anti-CX32	Rash JE, et al.	J Neurosci	21	1983-2000	2001	WB, Immunogold labeling
71-0600	Rb anti-CX32	Solomon IC, et al.	Respiration Path	129	101-121	2001	IHC
71-0600	Rb anti-CX32	Solomon IC, et al.	J Comp Neurol	440	19-Dec	2001	IHC IF
71-0600	Rb anti-CX32	Das Sarma J, et al.	J Biol Chem	277(23)	20911-20918	2002	IF
71-0600	Rb anti-CX32	Govindarajan R, et al.	J Biol Chem	277(51)	50087-50097	2002	ICC
71-0600	Rb anti-Cx32	Walcott B, et al.	Am J Physiol Cell Physiol	282	C501-507	2002	ICC (Ms)
71-0600	Rb anti-Cx32	Dufresne J, et al.	Am J Physiol Cell Physiol	284	C33-43	2003	ICC (rat)
71-0600	Rb anti-CX32	El-Sabban ME, et al.	J Cell Sci	116